98319-26-7 | Finasteride

Packsize	Purity	Availability	Price	Discounted Price
50mg	≥95%	in stock	$48.00	$34.00
200mg	>98.0%(GC)	in stock	$64.00	$45.00
1g	95%	in stock	$74.00	$52.00
5g	95%	in stock	$163.00	$114.00
10g	95%	in stock	$251.00	$176.00
25g	95%	in stock	$403.00	$282.00

Description

• Catalog Number: AB48681
• Chemical Name: Finasteride
• CAS Number: 98319-26-7
• Molecular Formula: C23H36N2O2
• Molecular Weight: 372.5441
• MDL Number: MFCD00869737
• SMILES: O=C1C=C[C@]2([C@H](N1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)NC(C)(C)C)C)C
• NSC Number: 741485

Computed Properties

• Complexity: 678
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 7
• Heavy Atom Count: 27
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 2
• XLogP3: 3

Literature

• Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway.

  Chemico-biological interactions 20170925

• The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.

  Toxicology letters 20170104

• Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens.

  Psychoneuroendocrinology 20161201

• Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.

  Toxicology and applied pharmacology 20161115

• Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish.

  Toxicology and applied pharmacology 20160815

• Effects of resveratrol on benign prostatic hyperplasia by the regulation of inflammatory and apoptotic proteins.

  Journal of natural products 20150424

• In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.

  Toxicology letters 20150122

• Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.

  Toxicological sciences : an official journal of the Society of Toxicology 20140101

• Effects of low dose treatment of tributyltin on the regulation of estrogen receptor functions in MCF-7 cells.

  Toxicology and applied pharmacology 20130601

• Homologous recombination induced by doxazosin mesylate and saw palmetto in the Drosophila wing-spot test.

  Journal of applied toxicology : JAT 20130301

• Prostate effect in dogs with the aldosterone receptor blocker eplerenone.

  Toxicologic pathology 20130201

• Finasteride and methadone use and risk of advanced hepatitis C related liver disease.

  Digestive diseases and sciences 20121101

• Persistent sexual side effects of finasteride: could they be permanent?

  The journal of sexual medicine 20121101

• A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.

  International journal of clinical practice 20121101

• Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

  Psychoneuroendocrinology 20121001

• Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

  BJU international 20121001

• Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20121001

• Benign prostatic hyperplasia (BPH) management in the primary care setting.

  The Canadian journal of urology 20121001

• Health-related quality-of-life findings for the prostate cancer prevention trial.

  Journal of the National Cancer Institute 20120919

• Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.

  Cancer 20120901

• Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.

  BJU international 20120901

• Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.

  Journal of the American Academy of Dermatology 20120901

• Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.

  Steroids 20120901

• Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5α-reductase inhibitors markedly enhances the detection rate of prostate cancer.

  The Journal of urology 20120901

• Expectant management of localized prostate cancer--who, what, when, where and how?

  The Journal of urology 20120901

• Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

  Epilepsy & behavior : E&B 20120901

• Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.

  The Journal of clinical psychiatry 20120901

• Finasteride reduces the risk of incident clinical benign prostatic hyperplasia.

  European urology 20120801

• A randomized double blind, vehicle controlled bilateral comparison study of the efficacy and safety of finasteride 0.5% solution in combination with intense pulsed light in the treatment of facial hirsutism.

  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20120801

• Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.

  European journal of medicinal chemistry 20120801

• Efficacy of Finasteride 1.25 mg on Female Pattern Hair Loss; Pilot Study.

  Annals of dermatology 20120801

• Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.

  Cutis 20120801

• Caspase-1 level is higher in the scalp in androgenetic alopecia.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20120701

• Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.

  Fitoterapia 20120701

• Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats.

  Journal of medicinal food 20120701

• NSAIDs induce apoptosis in nonproliferating ovarian cancer cells and inhibit tumor growth in vivo.

  IUBMB life 20120701

• A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

  The oncologist 20120701

• Finasteride and prostate cancer: a commentary.

  The oncologist 20120701

• [Finasteride in the treatment of benign prostatic hyperplasia].

  Der Urologe. Ausg. A 20120701

• Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.

  World journal of urology 20120601

• Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.

  Genetic testing and molecular biomarkers 20120601

• A mouse kindling model of perimenstrual catamenial epilepsy.

  The Journal of pharmacology and experimental therapeutics 20120601

• Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.

  Urology 20120601

• Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats.

  Fertility and sterility 20120601

• Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period.

  Fertility and sterility 20120601

• Finasteride attenuates pathological gambling in patients with Parkinson disease.

  Journal of clinical psychopharmacology 20120601

• Promising therapies for treating and/or preventing androgenic alopecia.

  Skin therapy letter 20120601

• The large sample bounds on the principal strata effect with application to a prostate cancer prevention trial.

  The international journal of biostatistics 20120521

• Comment on 'Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer' by Hsieh et al.

  The Prostate 20120515

• Prostate, baldness drugs linked to sexual dysfunction.

  JAMA 20120509

• Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats.

  Andrologia 20120501

• Effect of red maca (Lepidium meyenii) on prostate zinc levels in rats with testosterone-induced prostatic hyperplasia.

  Andrologia 20120501

• Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats.

  Andrologia 20120501

• Finasteride-related Leydig cell tumour: report of a case and literature review.

  Andrologia 20120501

• Blood donors on teratogenic drugs and donor deferral periods in a clinical situation.

  Vox sanguinis 20120501

• Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride.

  The Journal of steroid biochemistry and molecular biology 20120501

• 5α-Reductase, an enzyme regulating glucocorticoid action in the testis of Rhinella arenarum (Amphibia: Anura).

  General and comparative endocrinology 20120501

• Effects of oral finasteride on erectile function in a rat model.

  The journal of sexual medicine 20120501

• [Prevention of uro-oncological diseases].

  Der Urologe. Ausg. A 20120501

• [Chemoprevention of prostate cancer - a plea].

  Aktuelle Urologie 20120501

• High-grade prostatic intraepithelial neoplasia.

  Korean journal of urology 20120501

• Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.

  Investigational new drugs 20120401

• Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1.

  International urology and nephrology 20120401

• Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study.

  International urology and nephrology 20120401

• Role of neurosteroids in the anticonvulsant activity of midazolam.

  British journal of pharmacology 20120401

• Finasteride as a potential tool to improve mesenchymal stem cell transplantation for myocardial infarction.

  Medical hypotheses 20120401

• Allopregnanolone and induction of endogenous opioid inhibition of oxytocin responses to immune stress in pregnant rats.

  Journal of neuroendocrinology 20120401

• Combination pharmacological therapies for the management of benign prostatic hyperplasia.

  Drugs & aging 20120401

• α-blocker monotherapy and α-blocker plus 5-alpha-reductase inhibitor combination treatment in benign prostatic hyperplasia; 10 years' long-term results.

  Korean journal of urology 20120401

• The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.

  Regulatory toxicology and pharmacology : RTP 20120301

• Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.

  Current diabetes reviews 20120301

• Stable isotope dilution assay for the accurate determination of mycotoxins in maize by UHPLC-MS/MS.

  Analytical and bioanalytical chemistry 20120301

• Dutasteride for the treatment of prostate-related conditions.

  Expert opinion on drug safety 20120301

• Benign prostatic hyperplasia: from bench to clinic.

  Korean journal of urology 20120301

• 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment.

  Journal of ethnopharmacology 20120215

• T cell-mediated acute localized exanthematous pustulosis caused by finasteride.

  The Journal of allergy and clinical immunology 20120201

• Guidelines for the management of androgenetic alopecia (2010).

  The Journal of dermatology 20120201

• Re: comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).

  The Journal of urology 20120201

• Effect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.

  Korean journal of urology 20120201

• Investigation of the mechanisms of progesterone protection following oxygen-glucose deprivation in organotypic hippocampal slice cultures.

  Neuroscience letters 20120106

• Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite.

  The British journal of dermatology 20120101

• Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain.

  Pain 20120101

• A multi-technique approach to the study of structural stability and desolvation of two unusual channel hydrate solvates of finasteride.

  Journal of pharmaceutical sciences 20120101

• Ethnobiology and Ethnopharmacology of Lepidium meyenii (Maca), a Plant from the Peruvian Highlands.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.

  The Journal of dermatology 20120101

• Finasteride adherence-associated factors in Chinese benign prostatic hyperplasia patients.

  Urologia internationalis 20120101

• Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type A injection.

  BMC urology 20120101

• The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases.

  Advances in urology 20120101

• The effect of finasteride and dutasteride on the growth of WPE1-NA22 prostate cancer xenografts in nude mice.

  PloS one 20120101

• Obesity, body composition, and prostate cancer.

  BMC cancer 20120101

• 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis.

  Cancer cell international 20120101

• Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.

  PloS one 20120101

• Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy.

  Indian journal of nephrology 20120101

• Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates.

  Clinical epidemiology 20120101

• The reciprocal regulation of stress hormones and GABA(A) receptors.

  Frontiers in cellular neuroscience 20120101

• Usefulness of preoperative serum testosterone as a predictor of extraprostatic extension and biochemical recurrence.

  Korean journal of urology 20120101

• Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades.

  Korean journal of urology 20120101

• Progesterone synthesis in the nervous system: implications for myelination and myelin repair.

  Frontiers in neuroscience 20120101

• Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice.

  PloS one 20120101

• Prostate cancers detected during 5α-reductase inhibitor use are smaller, de-differentiated, but confined when compared to controls.

  Journal of Cancer 20120101

• An isolated neurofibromal polyp of the colon.

  Case reports in gastroenterology 20120101

• Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

  International journal of endocrinology 20120101

• Testosterone and vascular function in aging.

  Frontiers in physiology 20120101

• The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.

  Indian journal of urology : IJU : journal of the Urological Society of India 20120101

• Pure small cell carcinoma of the prostate: A rare tumor.

  Indian journal of urology : IJU : journal of the Urological Society of India 20120101

• Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use.

  Dermatology research and practice 20120101

• The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.

  Urologia internationalis 20120101

• Can beverages grow hair on bald heads?

  International journal of trichology 20120101

• Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation.

  Frontiers in endocrinology 20120101

• Neurosteroid influences on sensitivity to ethanol.

  Frontiers in endocrinology 20120101

• Prostate cancer - a biomarker perspective.

  Frontiers in endocrinology 20120101

• Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era.

  Journal of oncology 20120101

• Muscular dystrophies at different ages: metabolic and endocrine alterations.

  International journal of endocrinology 20120101

• Facial hidradenitis suppurativa in a 28-year-old male responding to finasteride.

  Dermatology (Basel, Switzerland) 20120101

• Single port transvesical prostatectomy.

  International braz j urol : official journal of the Brazilian Society of Urology 20120101

• Brazilian blood donation eligibility criteria for dermatologic patients.

  Anais brasileiros de dermatologia 20120101

• A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.

  PloS one 20120101

• Do 5-ARIs have a role in preventing BPH?

  The Practitioner 20120101

• Treatment of female pattern hair loss.

  Skinmed 20120101

• Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes.

  Molecules (Basel, Switzerland) 20111230

• The involvement of the neurosteroid allopregnanolone in the antihyperalgesic effect of paroxetine in a rat model of neuropathic pain.

  Neuroreport 20111221

• Neurosteroidogenesis is required for the physiological response to stress: role of neurosteroid-sensitive GABAA receptors.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20111214

• Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.

  International journal of andrology 20111201

• Sphaeranthus indicus attenuates testosterone induced prostatic hypertrophy in albino rats.

  Phytotherapy research : PTR 20111201

• Effects of in utero exposure to D-004, a lipid extract from Roystonea regia fruits, in the male rat: a comparison with finasteride.

  Journal of medicinal food 20111201

• What's wrong with chemoprevention of prostate cancer?

  The American journal of bioethics : AJOB 20111201

• Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.

  The British journal of dermatology 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Alteration of ethanol drinking in mice via modulation of the GABA(A) receptor with ganaxolone, finasteride, and gaboxadol.

  Alcoholism, clinical and experimental research 20111101

• New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors.

  Steroids 20111101

• Protective effects of finasteride on the pulmonary immune response in a combined model of trauma-hemorrhage and polymicrobial sepsis in mice.

  Cytokine 20111101

• New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.

  The Journal of steroid biochemistry and molecular biology 20111101

• A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.

  Asian journal of andrology 20111101

• Inhibition of 5α-reductase activity in late pregnancy decreases gestational length and fecundity and impairs object memory and central progestogen milieu of juvenile rat offspring.

  Journal of neuroendocrinology 20111101

• The benefit of stratification in clinical trials revisited.

  Statistics in medicine 20111030

• Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms.

  BMJ quality & safety 20111001

• Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

  Carcinogenesis 20111001

• [Primary prevention of urologic tumors: prostate cancer].

  Der Urologe. Ausg. A 20111001

• Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.

  Korean journal of urology 20111001

• Adolescent androgenic alopecia.

  Cutis 20111001

• Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110915

• WITHDRAWN: Terazosin for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20110907

• Effect of Citrullus colocynthis Schrad fruits on testosterone-induced alopecia.

  Natural product research 20110901

• National-wide data on the treatment of BPH in Korea.

  Prostate cancer and prostatic diseases 20110901

• A preliminary study of finasteride in Tourette syndrome.

  Movement disorders : official journal of the Movement Disorder Society 20110901

• [Prostate cancer. Current and practice-relevant news from urology in 2011].

  Der Urologe. Ausg. A 20110901

• Changes in sexual function in benign prostatic hyperplasia patients taking dutasteride: 1-year follow-up results.

  Korean journal of urology 20110901

• Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

  International neurourology journal 20110901

• Influence of dosing time on the efficacy and safety of finasteride in rats.

  The Journal of pharmacology and experimental therapeutics 20110801

• Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).

  BJU international 20110801

• Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.

  Cancer causes & control : CCC 20110801

• Oral finasteride improved the quality of life of androgenetic alopecia patients.

  The Journal of dermatology 20110801

• [Does St. John's wort interact with finasteride?].

  Deutsche medizinische Wochenschrift (1946) 20110801

• Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

  Journal of medicinal chemistry 20110714

• The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.

  The New England journal of medicine 20110714

• Ethanol enhances neurosteroidogenesis in hippocampal pyramidal neurons by paradoxical NMDA receptor activation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20110706

• Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

  Psychoneuroendocrinology 20110701

• Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory?

  Journal of general internal medicine 20110701

• Polymorphic CAG repeat numbers in the androgen receptor gene of female pattern hair loss patients.

  The Journal of dermatology 20110701

• Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.

  Journal of neuroendocrinology 20110701

• Finasteride-associated cataract and intraoperative floppy-iris syndrome.

  Journal of cataract and refractive surgery 20110701

• Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.

  The Prostate 20110701

• Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint II. Role of progesterone metabolites.

  Hormones and behavior 20110701

• Synthesis, antiproliferative activity, acute toxicity and assessment of the antiandrogenic activities of new androstane derivatives.

  Archives of pharmacal research 20110701

• Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia.

  Korean journal of urology 20110701

• Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

  American journal of epidemiology 20110615

• Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

  American journal of epidemiology 20110615

• Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments.

  Neuropharmacology 20110601

• Persistent sexual side effects of finasteride for male pattern hair loss.

  The journal of sexual medicine 20110601

• Synthesis and bioactivity of new Finasteride conjugate.

  Bioorganic & medicinal chemistry letters 20110601

• Finasteride-induced pseudoporphyria.

  Archives of dermatology 20110601

• Current status of transurethral prostatectomy: a korean multicenter study.

  Korean journal of urology 20110601

• Tamsulosin Monotherapy versus Combination Therapy with Antibiotics or Anti-Inflammatory Agents in the Treatment of Chronic Pelvic Pain Syndrome.

  International neurourology journal 20110601

• Targeting 5α-reductase for prostate cancer prevention and treatment.

  Nature reviews. Urology 20110531

• The antiandrogenic effect of finasteride against a mutant androgen receptor.

  Cancer biology & therapy 20110515

• Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.

  The Journal of steroid biochemistry and molecular biology 20110501

• Finasteride-induced secondary infertility associated with sperm DNA damage.

  Fertility and sterility 20110501

• In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole.

  Drug metabolism and disposition: the biological fate of chemicals 20110501

• [Non dietetic environmental risk factors in prostate cancer].

  Actas urologicas espanolas 20110501

• Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.

  Journal of Korean medical science 20110501

• Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.

  Bioorganic & medicinal chemistry letters 20110415

• Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample.

  World journal of urology 20110401

• Cyclic estrogenic fluctuation influences synaptic transmission of the medial vestibular nuclei in female rats.

  Acta oto-laryngologica 20110401

• Finasteride-associated male infertility.

  Fertility and sterility 20110401

• Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells.

  Molecular endocrinology (Baltimore, Md.) 20110401

• Finasteride for chronic central serous chorioretinopathy.

  Retina (Philadelphia, Pa.) 20110401

• Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial.

  The Journal of urology 20110401

• Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20110401

• Comparison of effectiveness of monopolar and bipolar transurethral resection of the prostate and open prostatectomy in large benign prostatic hyperplasia.

  Korean journal of urology 20110401

• Improving lower urinary tract symptoms in BPH.

  The Practitioner 20110401

• Effects of the chronic use of finasteride and doxazosin mesylate on the histomorphometric characteristics of the prostate: experimental study in rats.

  International urology and nephrology 20110301

• Delaying treatment in male-pattern hair loss affects the therapeutic response.

  Clinical and experimental dermatology 20110301

• Sex-dependent effect of a low neurosteroid environment and intrauterine growth restriction on foetal guinea pig brain development.

  The Journal of endocrinology 20110301

• The influence of family history on prostate cancer risk: implications for clinical management.

  BJU international 20110301

• Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.

  The journal of sexual medicine 20110301

• Increase in formalin-induced tonic pain by 5alpha-reductase and aromatase inhibition in female rats.

  Pharmacology, biochemistry, and behavior 20110301

• Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer.

  The Journal of urology 20110301

• Combined toxic exposures and human health: biomarkers of exposure and effect.

  International journal of environmental research and public health 20110301

• 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20110201

• The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males.

  General and comparative endocrinology 20110201

• Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening.

  Drug metabolism and disposition: the biological fate of chemicals 20110201

• The effects of 5α-reductase inhibition on benign prostatic hyperplasia treated by photoselective vaporization prostatectomy with the 120 Watt GreenLight HPS laser system.

  Journal of the American College of Surgeons 20110201

• [How effective is finasteride?].

  Deutsche medizinische Wochenschrift (1946) 20110201

• Importation of prescription medicines into New Zealand: a snapshot of intercepted products.

  International journal of clinical pharmacy 20110201

• Benign prostatic hyperplasia: An overview of existing treatment.

  Indian journal of pharmacology 20110201

• Serum levels of hypothalamic-pituitary-testicular axis hormones in men with or without prostate cancer or atypical small acinar proliferation.

  Clinics (Sao Paulo, Brazil) 20110201

• Interaction between early postnatal neurosteroid manipulations and adult infusion of neurosteroids into CA1 hippocampal region on the open field behaviour.

  Behavioural brain research 20110120

• Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies.

  Journal of medicinal chemistry 20110113

• Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.

  JAMA 20110105

• Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic Acid and saw palmetto extract.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Change in International Prostate Symptom storage subscore after long-term medical therapy in BPH patients: finasteride and alpha-blocker combination therapy in men with moderate-to-severe LUTS/BPH in Korea.

  Urology 20110101

• Neuroactive steroids induce changes in fetal sheep behavior during normoxic and asphyxic states.

  Stress (Amsterdam, Netherlands) 20110101

• A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells.

  Medical hypotheses 20110101

• Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.

  Bioorganic & medicinal chemistry letters 20110101

• Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.

  Cancer causes & control : CCC 20110101

• Immunomodulation in polytrauma and polymicrobial sepsis - where do we stand?

  Recent patents on inflammation & allergy drug discovery 20110101

• Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.

  CA: a cancer journal for clinicians 20110101

• Expression profiles of reproduction- and thyroid hormone-related transcripts in the brains of chemically-induced intersex frogs.

  Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 20110101

• An 82-year-old Caucasian man with a ductal prostate adenocarcinoma with unusual cystoscopic appearance: a case report.

  Journal of medical case reports 20110101

• Prostate cancer prevention with 5 alpha-reductase inhibitors.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

• Effect of Aike Mixture on the inflammatory infiltration in patients with chronic prostatitis type III A.

  Chinese journal of integrative medicine 20110101

• Does finasteride have a preventive effect on chronic bacterial prostatitis? Pilot study using an animal model.

  Urologia internationalis 20110101

• Specific pharmacokinetic aspects of the urinary tract.

  Handbook of experimental pharmacology 20110101

• Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.

  PloS one 20110101

• Determination of finasteride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with flow rate gradient.

  European journal of drug metabolism and pharmacokinetics 20110101

• Experimental trauma models: an update.

  Journal of biomedicine & biotechnology 20110101

• Treatment options for polycystic ovary syndrome.

  International journal of women's health 20110101

• Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of α(4)/δ GABA(A) Receptor Gene Expression and Function in the Hippocampus of C57BL/6J Mice.

  Frontiers in neuroscience 20110101

• Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.

  Current pharmaceutical design 20110101

• Long-term efficacy and safety of tamsulosin hydrochloride for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: data from China.

  Chinese medical journal 20110101

• Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.

  Dermatologic therapy 20110101

• The role of intraprostatic inflammation in the acute urinary retention.

  International journal of preventive medicine 20110101

• Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.

  Urologia internationalis 20110101

• 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis.

  Neuropharmacology 20110101

• Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies.

  Anemia 20110101

• Genetic analysis of the neurosteroid deoxycorticosterone and its relation to alcohol phenotypes: identification of QTLs and downstream gene regulation.

  PloS one 20110101

• DHT deficiency perturbs the integrity of the rat seminiferous epithelium by disrupting tight and adherens junctions.

  Folia histochemica et cytobiologica 20110101

• Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer.

  PloS one 20110101

• How to reduce your cancer risk: mechanisms and myths.

  International journal of general medicine 20110101

• Effects of electroacupuncture on benign prostate hyperplasia patients with lower urinary tract symptoms: a single-blinded, randomized controlled trial.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.

  PloS one 20110101

• Chemoprevention of prostate cancer with nutrients and supplements.

  Cancer management and research 20110101

• Group-ICA Model Order Highlights Patterns of Functional Brain Connectivity.

  Frontiers in systems neuroscience 20110101

• Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence.

  Molecular medicine (Cambridge, Mass.) 20110101

• Hirsutism: evaluation and treatment: a reader's dilemma.

  Indian journal of dermatology 20110101

• Author'S reply.

  Indian journal of dermatology 20110101

• Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice.

  PloS one 20110101

• Computer aided screening of inhibitors to 5-α reductase type 2 for prostate cancer.

  Bioinformation 20110101

• Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia.

  Therapeutics and clinical risk management 20110101

• [Risk factors and prevention actions in prostate cancer: fundamentals for nursing].

  Revista brasileira de enfermagem 20110101

• A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia.

  Current medicinal chemistry 20110101

• Serendipity in trichology.

  International journal of trichology 20110101

• Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability.

  Genome medicine 20110101

• Medical treatment of benign prostatic hyperplasia.

  Reviews in urology 20110101

• Endogenous synthesis of corticosteroids in the hippocampus.

  PloS one 20110101

• Alopecia: evaluation and treatment.

  Clinical, cosmetic and investigational dermatology 20110101

• [Methotrexate to treat SAPHO syndrome with keloidal scars].

  Acta reumatologica portuguesa 20110101

• The Hirsute woman: challenges in evaluation and management.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101

• Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer.

  Journal of biomedical science 20110101

• Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report.

  Journal of medical case reports 20110101

• Acute pancreatitis with saw palmetto use: a case report.

  Journal of medical case reports 20110101

• State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

  International journal of pediatric endocrinology 20110101

• Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.

  Dermatologic therapy 20110101

• 5-α reductase inhibitors and prostate cancer prevention: where do we turn now?

  BMC medicine 20110101

• Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

  PloS one 20110101

• Quality of online pharmacies and websites selling prescription drugs: a systematic review.

  Journal of medical Internet research 20110101

• Liquid formulation of minoxidil versus its foam formulation.

  Indian journal of dermatology 20110101

• Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability.

  Patient preference and adherence 20110101

• Valorising and creating access to innovative medicines in the European union.

  Frontiers in pharmacology 20110101

• Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review.

  Frontiers in psychiatry 20110101

• The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people.

  BMC geriatrics 20110101

• Finasteride and male fertility.

  Journal of human reproductive sciences 20110101

• Cancer Risk and Behavioral Factors, Comorbidities, and Functional Status in the US Elderly Population.

  ISRN oncology 20110101

• Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.

  Advances in pharmacological sciences 20110101

• The impact in the agnors expression and apoptosis in the prostate of hamster-mesocricetus auratus (HMA) submitted to finasteride application.

  Revista do Colegio Brasileiro de Cirurgioes 20110101

• Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress.

  Frontiers in neuroscience 20110101

• Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence.

  Journal of carcinogenesis 20110101

• Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.

  PloS one 20110101

• Lifetime economic burden of prostate cancer.

  BMC health services research 20110101

• Biochemical bone turnover markers and osteoporosis in older men: where are we?

  Journal of osteoporosis 20110101

• Components of an anticancer diet: dietary recommendations, restrictions and supplements of the Bill Henderson Protocol.

  Nutrients 20110101

• Molecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex development.

  International journal of molecular sciences 20110101

• How to appraise the effectiveness of treatment.

  Indian journal of urology : IJU : journal of the Urological Society of India 20110101

• Hormones and prostate carcinogenesis: Androgens and estrogens.

  Journal of carcinogenesis 20110101

• Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.

  Frontiers in neuroscience 20110101

• What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.

  Journal of drugs in dermatology : JDD 20110101

• A novel potent tumour promoter aberrantly overexpressed in most human cancers.

  Scientific reports 20110101

• Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA.

  ISRN dermatology 20110101

• From models to crop species: caveats and solutions for translational metabolomics.

  Frontiers in plant science 20110101

• Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion.

  Frontiers in endocrinology 20110101

• Neuroprotective actions of neurosteroids.

  Frontiers in endocrinology 20110101

• Enhanced Sensitivity to Ethanol-Induced Inhibition of LTP in CA1 Pyramidal Neurons of Socially Isolated C57BL/6J Mice: Role of Neurosteroids.

  Frontiers in endocrinology 20110101

• Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.

  Frontiers in endocrinology 20110101

• Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy.

  Frontiers in endocrinology 20110101

• Neurosteroids and GABA-A Receptor Function.

  Frontiers in endocrinology 20110101

• Neurosteroids as neuromodulators in the treatment of anxiety disorders.

  Frontiers in endocrinology 20110101

• Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20101215

• Enhancement of percutaneous absorption of finasteride by cosolvents, cosurfactant and surfactants.

  Pharmaceutical development and technology 20101201

• Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.

  Prostate cancer and prostatic diseases 20101201

• Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.

  Toxicological sciences : an official journal of the Society of Toxicology 20101201

• Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.

  The Journal of urology 20101201

• Finasteride-induced depression: new insights into possible pathomechanisms.

  Journal of cosmetic dermatology 20101201

• Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

  Future oncology (London, England) 20101201

• Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

  Cancer prevention research (Philadelphia, Pa.) 20101201

• Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml.

  Korean journal of urology 20101201

• Analysis of initial baseline clinical parameters and treatment strategy associated with medication failure in the treatment of benign prostatic hyperplasia in Korea.

  International neurourology journal 20101201

• Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20101201

• Finasteride: male breast cancer.

  Prescrire international 20101201

• Successful drug development despite adverse preclinical findings part 2: examples.

  Journal of toxicologic pathology 20101201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Use of transgenic mice as models for prostate cancer chemoprevention.

  Current molecular medicine 20101101

• Update on the pathogenesis, genetics and medical treatment of patterned hair loss.

  Journal of drugs in dermatology : JDD 20101101

• Comparative effect of finasteride and dutasteride on chromogranin A levels.

  Anticancer research 20101101

• Finasteride for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20101006

• Two unusual cases of canine prostatitis: prostatitis in a castrated dog and preputial oedema in an intact male.

  Reproduction in domestic animals = Zuchthygiene 20101001

• Metyrapone blunts stress-induced hyperthermia and increased locomotor activity independently of glucocorticoids and neurosteroids.

  Psychoneuroendocrinology 20101001

• Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.

  The Prostate 20101001

• An in vitro model for preclinical testing of endocrine therapy combinations for prostate cancer.

  The Prostate 20101001

• Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.

  The Journal of urology 20101001

• From surgery to pharmacology to gene therapy: the past, present, and future of hair restoration.

  Annals of plastic surgery 20101001

• Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101001

• Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.

  Archives of dermatology 20101001

• Active surveillance for favorable-risk prostate cancer: a short review.

  Korean journal of urology 20101001

• The different reduction rate of prostate-specific antigen in dutasteride and finasteride.

  Korean journal of urology 20101001

• Progesterone and maternal aggressive behavior in rats.

  Behavioural brain research 20100901

• Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

  Asian journal of andrology 20100901

• Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.

  Endocrine-related cancer 20100901

• Evidence-based urology in practice: composite endpoints.

  BJU international 20100901

• Regulation of thyroid hormone-, oestrogen- and androgen-related genes by triiodothyronine in the brain of Silurana tropicalis.

  Journal of neuroendocrinology 20100901

• Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism.

  Southern medical journal 20100901

• Knowledge and use of finasteride for the prevention of prostate cancer.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20100901

• Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.

  Acta biologica Hungarica 20100901

• Evolving role of 5-alpha reductase inhibitors in chemoprevention.

  Nature reviews. Clinical oncology 20100901

• 82-year-old man with bilateral leg swelling.

  Mayo Clinic proceedings 20100901

• Dihydroartemisinin loaded nanostructured lipid carriers (DHA-NLC): evaluation of pharmacokinetics and tissue distribution after intravenous administration to rats.

  Die Pharmazie 20100901

• Acute hepatitis associated with the use of levofloxacin.

  Clinical therapeutics 20100901

• Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sediments.

  British journal of cancer 20100824

• Dutasteride and prostate cancer.

  The New England journal of medicine 20100819

• Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.

  The British journal of dermatology 20100801

• Temporal expression and steroidal regulation of piRNA pathway genes (mael, piwi, vasa) during Silurana (Xenopus) tropicalis embryogenesis and early larval development.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20100801

• Can chemoprevention reduce the risk of prostate cancer?

  Clinical chemistry 20100801

• Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.

  Advances in therapy 20100801

• Hematuria secondary to an internal iliac artery aneurysm.

  Korean journal of urology 20100801

• [Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis].

  Zhonghua nan ke xue = National journal of andrology 20100801

• [Interactions between St John's wort extract and finasteride?].

  Medizinische Monatsschrift fur Pharmazeuten 20100801

• Risks related to the use of finasteride (propecia) in pregnant women.

  American family physician 20100715

• Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

  Biostatistics (Oxford, England) 20100701

• Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.

  Steroids 20100701

• Treatment of benign essential blepharospasm with finasteride: a case report.

  Clinical neuropharmacology 20100701

• Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.

  The Journal of urology 20100701

• Finasteride treatment inhibits adult hippocampal neurogenesis in male mice.

  Pharmacopsychiatry 20100701

• Finasteride.

  Expert opinion on drug metabolism & toxicology 20100701

• The use of 5-alpha reductase inhibitors for the prevention of prostate cancer.

  Cancer biology & therapy 20100701

• Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography.

  Korean journal of urology 20100701

• Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia.

  Korean journal of urology 20100701

• Enzyme-linked immunosorbent assays for doping control of 5alpha-reductase inhibitors finasteride and dutasteride.

  Analytica chimica acta 20100625

• Rapid determination of finasteride in human plasma by UPLC-MS/MS and its application to clinical pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100615

• Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women.

  Fertility and sterility 20100601

• Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.

  International journal of andrology 20100601

• Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.

  Journal of enzyme inhibition and medicinal chemistry 20100601

• A pilot study of paternal drug exposure: the Motherisk experience.

  Reproductive toxicology (Elmsford, N.Y.) 20100601

• Synthesis, antiproliferative, acute toxicity and assessment of antiandrogenic activities of some newly synthesized steroidal lactams.

  European journal of medicinal chemistry 20100601

• Male androgenetic alopecia.

  Expert opinion on pharmacotherapy 20100601

• Finasteride treatment of hair loss in women.

  The Annals of pharmacotherapy 20100601

• Blood dripping from the penis of a German Shepherd dog.

  Australian veterinary journal 20100601

• Prostate cancer: finasteride extends PSA doubling time during intermittent hormone therapy.

  The Canadian journal of urology 20100601

• Editorial comment.

  The Canadian journal of urology 20100601

• Validated RP-HPLC and TLC methods for simultaneous estimation of tamsulosin hydrochloride and finasteride in combined dosage forms.

  Acta pharmaceutica (Zagreb, Croatia) 20100601

• [The influence of benign prostatic hyperplasia drugs on incidence and pathology grading of prostate cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20100515

• Alterations in neonatal neurosteroids affect exploration during adolescence and prepulse inhibition in adulthood.

  Psychoneuroendocrinology 20100501

• Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.

  BJU international 20100501

• Treatment with progesterone after focal cerebral ischemia suppresses proliferation of progenitor cells but enhances survival of newborn neurons in adult male mice.

  Neuropharmacology 20100501

• Update on chemoprevention for prostate cancer.

  Current opinion in urology 20100501

• Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

  The Journal of urology 20100501

• Endogenous neurosteroid synthesis modulates seizure frequency.

  Annals of neurology 20100501

• A practical guide to male hypogonadism in the primary care setting.

  International journal of clinical practice 20100501

• Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development.

  General and comparative endocrinology 20100401

• Mixture effects of endocrine disrupting compounds in vitro.

  International journal of andrology 20100401

• Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.

  Cancer prevention research (Philadelphia, Pa.) 20100401

• Chemoprevention of prostate cancer.

  The New England journal of medicine 20100401

• Low levels of the herbicide atrazine alter sex ratios and reduce metamorphic success in Rana pipiens tadpoles raised in outdoor mesocosms.

  Environmental health perspectives 20100401

• The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment.

  Korean journal of urology 20100401

• Hirsutism: Diagnosis and management.

  Gender medicine 20100401

• [Treatment of benign prostate hyperplasia].

  Orvosi hetilap 20100321

• Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice.

  Neuroscience 20100310

• Progesterone promotes the survival of newborn neurons in the dentate gyrus of adult male mice.

  Hippocampus 20100301

• A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

  International urology and nephrology 20100301

• Urticarial rush due to finasteride.

  Allergy 20100301

• Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100301

• Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system.

  Developmental neurobiology 20100301

• Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.

  Urology 20100301

• Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301

• Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

  Cancer prevention research (Philadelphia, Pa.) 20100301

• [The effect of hormonal agents on the development of chronic laryngitis and tumor disease. Report of two cases].

  HNO 20100301

• False-positive screening results in the Finnish prostate cancer screening trial.

  British journal of cancer 20100202

• Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate.

  International journal of andrology 20100201

• A liquid chromatography/tandem mass spectrometry method for determination of aristolochic acid-I in rat plasma.

  Biomedical chromatography : BMC 20100201

• Critical androgen-sensitive periods of rat penis and clitoris development.

  International journal of andrology 20100201

• Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model.

  The Prostate 20100201

• An overview on 5alpha-reductase inhibitors.

  Steroids 20100201

• 3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors: a self organizing molecular field analysis approach.

  European journal of medicinal chemistry 20100201

• High-grade prostate cancer and finasteride.

  BJU international 20100201

• Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.

  World journal of urology 20100201

• Anti-androgen treatments.

  Annales d'endocrinologie 20100201

• Effect of finasteride on serum prostate-specific antigen (PSA) and on prostate of hamster Mesocricetus auratus (hMa).

  Acta cirurgica brasileira 20100201

• Chemoprevention of prostate cancer.

  The Urologic clinics of North America 20100201

• Hair restoration in the ethnic patient and review of hair transplant fundamentals.

  Facial plastic surgery clinics of North America 20100201

• Assessment of information to substantiate a health claim on the prevention of prostate cancer by lignans.

  Nutrients 20100201

• Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats.

  European journal of pharmacology 20100125

• Hydrophobic solvent induced phase transition extraction to extract drugs from plasma for high performance liquid chromatography-mass spectrometric analysis.

  Journal of chromatography. A 20100115

• Effect of 1-mg dose of finasteride on spermatogenesis and pregnancy.

  Journal of andrology 20100101

• Allopregnanolone, the active metabolite of progesterone protects against neuronal damage in picrotoxin-induced seizure model in mice.

  Pharmacology, biochemistry, and behavior 20100101

• Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.

  Endocrine regulations 20100101

• [Red clover isoflavones inhibit the proliferation and promote the apoptosis of benign prostatic hyperplasia stromal cells].

  Zhonghua nan ke xue = National journal of andrology 20100101

• Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitors.

  Urologia internationalis 20100101

• What the hyena's laugh tells: sex, age, dominance and individual signature in the giggling call of Crocuta crocuta.

  BMC ecology 20100101

• Prostate cancer chemoprevention: what is the role of oncology nurses?

  Canadian oncology nursing journal = Revue canadienne de nursing oncologique 20100101

• Pharmacokinetics of 2 novel formulations of modified-release oral testosterone alone and with finasteride in normal men with experimental hypogonadism.

  Journal of andrology 20100101

• The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.

  Biology direct 20100101

• Hirsutism: evaluation and treatment.

  Indian journal of dermatology 20100101

• Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

  PloS one 20100101

• Saturable binding of finasteride to steroid 5alpha-reductase as determinant of nonlinear pharmacokinetics.

  Drug metabolism and pharmacokinetics 20100101

• Medical Treatment of Hirsutism in Women.

  Current medicinal chemistry 20100101

• Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

  BMC health services research 20100101

• Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.

  BMC cancer 20100101

• Management of the adult with congenital adrenal hyperplasia.

  International journal of pediatric endocrinology 20100101

• Frontal fibrosing alopecia: to treat or not to treat?

  Journal of cutaneous medicine and surgery 20100101

• Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.

  International journal of pediatric endocrinology 20100101

• Nonclassic congenital adrenal hyperplasia.

  International journal of pediatric endocrinology 20100101

• Surgical management of hidradenitis suppurativa.

  International journal of medical sciences 20100101

• Cancer biomarker discovery: the entropic hallmark.

  PloS one 20100101

• Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

  BMJ (Clinical research ed.) 20100101

• Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping.

  Molecular pain 20100101

• Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?

  Dermatologic therapy 20100101

• Etiology and management of urinary retention in women.

  Indian journal of urology : IJU : journal of the Urological Society of India 20100101

• [Treatment of prostatic adenoma].

  Urologiia (Moscow, Russia : 1999) 20100101

• Hair transplantation surgery - its current status.

  Journal of cutaneous and aesthetic surgery 20100101

• Review of factors affecting the growth and survival of follicular grafts.

  Journal of cutaneous and aesthetic surgery 20100101

• Controversy: is there a role for adjuvants in the management of male pattern hair loss?

  Journal of cutaneous and aesthetic surgery 20100101

• Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?

  Journal of cutaneous and aesthetic surgery 20100101

• Epidemiological analysis of doping offences in the professional tennis circuit.

  Journal of occupational medicine and toxicology (London, England) 20100101

• Ocular pharmacokinetics of 0.45% ketorolac tromethamine.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Mesotherapy in Management of Hairloss - Is it of Any Use?

  International journal of trichology 20100101

• What can surrogate tissues tell us about the oxidative stress status of the prostate? A hypothesis-generating in-vivo study.

  PloS one 20100101

• Steven Kossards postmenopausal frontal fibrosing alopecia (PFFA)--a therapeutic dilemma.

  Akusherstvo i ginekologiia 20100101

• Effect of Tectona grandis Linn. seeds on hair growth activity of albino mice.

  International journal of Ayurveda research 20100101

• Development and evaluation of formulations of microbial biotransformed extract of tobacco leaves for hair growth potential.

  Pharmacognosy research 20100101

• Niosome as a drug carrier for topical delivery of N-acetyl glucosamine.

  Research in pharmaceutical sciences 20100101

• Mesotherapy - The french connection.

  Journal of pharmacology & pharmacotherapeutics 20100101

• Patent protection strategies.

  Journal of pharmacy & bioallied sciences 20100101

• Therapeutic and cosmeceutical potential of ethosomes: An overview.

  Journal of advanced pharmaceutical technology & research 20100101

• Testosterone replacement in male hypogonadism.

  Clinical pharmacology : advances and applications 20100101

• Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.

  Journal of medicinal chemistry 20091210

• Three isostructural solvates of finasteride and their solid-state characterization.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091208

• Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.

  International journal of andrology 20091201

• Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate.

  Microscopy research and technique 20091201

• Puberty, steroids and GABA(A) receptor plasticity.

  Psychoneuroendocrinology 20091201

• Plasticity and function of extrasynaptic GABA(A) receptors during pregnancy and after delivery.

  Psychoneuroendocrinology 20091201

• Awareness of prostate cancer among patients and the general public: results of an international survey.

  Prostate cancer and prostatic diseases 20091201

• Progesterone and allopregnanolone enhance the miniature synaptic release of glycine in the rat hypoglossal nucleus.

  The European journal of neuroscience 20091201

• Synergistic disruption of external male sex organ development by a mixture of four antiandrogens.

  Environmental health perspectives 20091201

• Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the hepg2 hepatocellular carcinoma cell line and the lncap prostate cancer cell line.

  Environmental health perspectives 20091201

• Fasting and cancer treatment in humans: A case series report.

  Aging 20091201

• Exposure of Xenopus laevis tadpoles to finasteride, an inhibitor of 5-alpha reductase activity, impairs spermatogenesis and alters hypophyseal feedback mechanisms.

  Journal of molecular endocrinology 20091101

• Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach.

  Urology 20091101

• Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase.

  BJU international 20091101

• Contemporary hair transplantation.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20091101

• Prostate cancer prevention (AUGUST 2009).

  Cleveland Clinic journal of medicine 20091101

• Anogenital distance from birth to 2 years: a population study.

  Environmental health perspectives 20091101

• Inappropriate sexual behaviors in patients with vascular dementia: possible response to finasteride.

  Journal of the American Geriatrics Society 20091101

• Role of neurosteroids in regulating cell death and proliferation in the late gestation fetal brain.

  Neuroscience 20091020

• Guideline for 5-alpha-reductase inhibitors in the prevention of prostate cancer is premature.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020

• Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.

  Steroids 20091001

• Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20091001

• Alopecia secondary to mesotherapy.

  Journal of the American Academy of Dermatology 20091001

• Olanzapine plus 17-beta estradiol produce antidepressant-like actions in rats forced to swim.

  Pharmacology, biochemistry, and behavior 20091001

• Identification of finasteride metabolites in human bile and urine by high-performance liquid chromatography/tandem mass spectrometry.

  Drug metabolism and disposition: the biological fate of chemicals 20091001

• Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

  Nature chemical biology 20091001

• Hair loss in women.

  Minerva ginecologica 20091001

• Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.

  Clinical therapeutics 20091001

• On call. My brother needed surgery for an enlarged prostate at age 60. I am a few months shy of my 50th birthday, and my urine stream is starting to slow down a bit. Is there anything I can do to avoid following in my brother's footsteps?

  Harvard men's health watch 20091001

• Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.

  Surgical oncology 20090901

• Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania.

  Diabetes 20090901

• Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

  British journal of cancer 20090901

• Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.

  Journal of neuroscience research 20090815

• Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

  Cancer 20090815

• Diagnosing and treating hair loss.

  American family physician 20090815

• Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up.

  BJU international 20090801

• A systematic evaluation of factors associated with nocturia--the population-based FINNO study.

  American journal of epidemiology 20090801

• Chemoprevention of prostate cancer.

  The Journal of urology 20090801

• Effects of Kangquan Recipe on sex steroids and cell proliferation in rats with benign prostatic hyperplasia.

  Chinese journal of integrative medicine 20090801

• Pharmacological options for treatment of hyperandrogenic disorders.

  Mini reviews in medicinal chemistry 20090801

• When you just can't go: my patient, a 63-year old stockbroker, recalled his experience with acute urinary retention.

  Consumer reports 20090801

• Inhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex.

  The Journal of biological chemistry 20090724

• The influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090715

• High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series.

  British journal of cancer 20090707

• The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

  Psychopharmacology 20090701

• Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts.

  The Journal of steroid biochemistry and molecular biology 20090701

• Is it worth the wait?

  BJU international 20090701

• N-tert-Butyl-3-hydr-oxy-5-androstene-17-carboxamide monohydrate.

  Acta crystallographica. Section E, Structure reports online 20090701

• Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.

  Journal of enzyme inhibition and medicinal chemistry 20090601

• A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.

  The Prostate 20090601

• Androgens and hair loss.

  Current opinion in endocrinology, diabetes, and obesity 20090601

• The use of low-level light for hair growth: part I.

  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20090601

• Molecular profiles of finasteride effects on prostate carcinogenesis.

  Cancer prevention research (Philadelphia, Pa.) 20090601

• Elocalcitol, a vitamin D3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility.

  IDrugs : the investigational drugs journal 20090601

• The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?

  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20090601

• Gleason grading controversies: what the chemoprevention trials have taught us.

  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20090601

• Finasteride to prevent prostate cancer: a new chapter.

  Harvard men's health watch 20090601

• By the way, doctor. Finasteride has been prescribed for my BPH. I think that the most frequent side effect is erectile dysfunction or loss of sexual desire. Would Levita or a similar drug (like Viagra or Cialis) overcome the side effects of finasteride?

  Harvard health letter 20090601

• Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090520

• Guideline supports long-term use of medication to lower prostate cancer risk.

  JAMA 20090506

• Microemulsions as a surrogate carrier for dermal drug delivery.

  Drug development and industrial pharmacy 20090501

• Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.

  European urology 20090501

• Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.

  European urology 20090501

• Pharmacological approaches to reducing the risk of prostate cancer.

  European urology 20090501

• Neuroactive steroids inhibit spinal reflex potentiation by selectively enhancing specific spinal GABA(A) receptor subtypes.

  Pain 20090501

• Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.

  The Journal of urology 20090501

• The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.

  Current opinion in urology 20090501

• PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.

  Urology 20090501

• Overview of pivotal studies for prostate cancer risk reduction, past and present.

  Urology 20090501

• Editorial comment.

  Urology 20090501

• [Medicolegal aspects of doping and dermatology].

  Annales de dermatologie et de venereologie 20090501

• Continuous finasteride therapy for benign prostate hypertrophy upgrades both neuroendorcine differentiation and aggressive prostate cancer.

  Anticancer research 20090501

• D-004, a lipid extract from royal palm fruit, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.

  Pharmacology, biochemistry, and behavior 20090501

• Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.

  Bioorganic & medicinal chemistry letters 20090415

• Serenoa repens for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20090415

• Validated UPLC method for the fast and sensitive determination of steroid residues in support of cleaning validation in formulation area.

  Journal of pharmaceutical and biomedical analysis 20090405

• Effect of discontinuation of 5alpha-reductase inhibitors on prostate volume and symptoms in men with BPH: a prospective study.

  Urology 20090401

• Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.

  Bioorganic & medicinal chemistry 20090401

• Prostate cancer: a serious disease suitable for prevention.

  BJU international 20090401

• Treatment strategies for alopecia.

  Expert opinion on pharmacotherapy 20090401

• On call. I am 76 years old, and I've had an enlarged prostate for at least 10 years. I've been taking Proscar for about a year, and it seems to be helping quite a bit. I have not noticed any side effects, but I'm worried that if the medicine reduces testosterone levels enough to shrink my prostate, it will also give me osteoporosis. Should I change medications, or take Fosamax like my wife?

  Harvard men's health watch 20090401

• A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.

  Indian journal of pharmacology 20090401

• 5-Alpha reductase inhibitors and risk of hip fracture.

  JAMA 20090304

• The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090302

• Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats.

  Psychopharmacology 20090301

• Molecular targets for cancer chemoprevention.

  Nature reviews. Drug discovery 20090301

• Hair loss in women.

  Seminars in cutaneous medicine and surgery 20090301

• N-tert-Butyl-5α-androstane-17β-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20090301

• Changes in expression and function of extrasynaptic GABAA receptors in the rat hippocampus during pregnancy and after delivery.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090211

• Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.

  The Journal of urology 20090201

• Finasteride and high-grade prostate cancer.

  Cancer prevention research (Philadelphia, Pa.) 20090201

• Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages.

  International journal of experimental pathology 20090201

• 5alpha-dihydrotestosterone (DHT) retards wound closure by inhibiting re-epithelialization.

  The Journal of pathology 20090101

• 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.

  Prostate cancer and prostatic diseases 20090101

• A case of gastrointestinal stromal tumor diagnosed on prostate biopsy.

  Nature clinical practice. Urology 20090101

• Development of novel cosmetic base using sterol surfactant. II. Solubilizing of sparingly soluble ultraviolet ray absorbers.

  Journal of oleo science 20090101

• Solitary fixed drug eruption caused by finasteride.

  Journal of the American Academy of Dermatology 20090101

• Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period.

  Epilepsia 20090101

• Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia.

  Indian journal of dermatology, venereology and leprology 20090101

• Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy.

  Prostate cancer and prostatic diseases 20090101

• [Finasteride: an effective therapeutic for benign prostatic hyperplasia related gross hematuria in patients receiving anticoagulant].

  Zhonghua nan ke xue = National journal of andrology 20090101

• Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy.

  Scandinavian journal of urology and nephrology 20090101

• Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases.

  BMC cancer 20090101

• Aphalangia possibly linked to unintended use of finasteride during early pregnancy.

  Annals of Saudi medicine 20090101

• A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism.

  Journal of endocrinological investigation 20090101

• Antibiotic and anti-inflammatory use and the risk of prostate cancer.

  BMC research notes 20090101

• A slippery preventive slope.

  The Hastings Center report 20090101

• The expression of inducible nitric oxide synthase (iNOS) in the testis and epididymis of rats with a dihydrotestosterone (DHT) deficiency.

  Cellular & molecular biology letters 20090101

• Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.

  Urologic oncology 20090101

• Clients' reasons for prenatal ultrasonography in Ibadan, South West of Nigeria.

  BMC women's health 20090101

• Finasteride-induced gynecomastia.

  Indian journal of dermatology, venereology and leprology 20090101

• PCOS.

  BMJ clinical evidence 20090101

• Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.

  Drug safety 20090101

• The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms.

  Health and quality of life outcomes 20090101

• Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.

  Clinical interventions in aging 20090101

• Screening for prostate cancer.

  CA: a cancer journal for clinicians 20090101

• Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study.

  Cardiovascular diabetology 20090101

• GABA(A) receptor function and gene expression during pregnancy and postpartum.

  International review of neurobiology 20090101

• Gene expression in hair follicle dermal papilla cells after treatment with stanozolol.

  Biomarker insights 20090101

• Finasteride treatment and neuroactive steroid formation.

  Prague medical report 20090101

• The benefits and risks of testosterone replacement therapy: a review.

  Therapeutics and clinical risk management 20090101

• Finasteride in the treatment of patients with benign prostatic hyperplasia: a review.

  Therapeutics and clinical risk management 20090101

• Cyproterone acetate quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization tandem mass spectrometry. Application to a comparative pharmacokinetics study.

  Arzneimittel-Forschung 20090101

• Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.

  International journal of chronic obstructive pulmonary disease 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Etiopathogenesis of benign prostatic hypeprlasia.

  Indian journal of urology : IJU : journal of the Urological Society of India 20090101

• Therapeutic options in the treatment of benign prostatic hyperplasia.

  Patient preference and adherence 20090101

• Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report.

  Cases journal 20090101

• Why some women look young for their age.

  PloS one 20090101

• Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

  PloS one 20090101

• Effect of spinal cord injury upon prostate: adenocarcinoma of prostate in a spinal cord injury patient - a case report.

  Cases journal 20090101

• Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia.

  Nutrition research and practice 20090101

• Vestibulocochlear toxicity in a pair of siblings 15 years apart secondary to aspartame: two case reports.

  Cases journal 20090101

• The aromatase inhibitor fadrozole and the 5-reductase inhibitor finasteride affect gonadal differentiation and gene expression in the frog Silurana tropicalis.

  Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 20090101

• [Efficacy and safety of combined treatment of prostatic adenoma with 5-alpha reductase and alpha-adrenoblockers].

  Urologiia (Moscow, Russia : 1999) 20090101

• [The role of combined treatment of prostatic gland after biopsy of the prostate for an elevated PSA level].

  Urologiia (Moscow, Russia : 1999) 20090101

• Increased frequency and nocturia in a middle aged male may not always be due to benign prostatic hypertrophy: a case report.

  Cases journal 20090101

• [Efficacy of combined treatment of large prostatic adenoma with doxasozine and finasteride].

  Urologiia (Moscow, Russia : 1999) 20090101

• Finasteride-its impact on sexual function and prostate cancer.

  Journal of cutaneous and aesthetic surgery 20090101

• Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?

  Journal of cutaneous and aesthetic surgery 20090101

• Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit.

  Indian journal of pharmaceutical sciences 20090101

• Oxidative stress in ageing of hair.

  International journal of trichology 20090101

• Finasteride induced Gynecomastia: Case report and Review of the Literature.

  International journal of trichology 20090101

• Minoxidil topical foam: a new kid on the block.

  International journal of trichology 20090101

• Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

  American journal of epidemiology 20081215

• The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice.

  Brain research 20081203

• Antipsychotic-like properties of 5-alpha-reductase inhibitors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Studies on neurosteroids XXIV. Determination of neuroactive androgens, androsterone and 5alpha-androstane-3alpha,17beta-diol, in rat brain and serum using liquid chromatography-tandem mass spectrometry.

  Biomedical chromatography : BMC 20081201

• The role of combination medical therapy in benign prostatic hyperplasia.

  International journal of impotence research 20081201

• Finasteride for prostatic disease: an updated and comprehensive review.

  Expert opinion on drug metabolism & toxicology 20081201

• 5-alpha reductase inhibitors and erectile dysfunction: the connection.

  The journal of sexual medicine 20081201

• Finasteride-induced myalgia and HyperCKemia.

  Journal of clinical neuromuscular disease 20081201

• Laboratory diagnosis of late-onset male hypogonadism andropause.

  Arquivos brasileiros de endocrinologia e metabologia 20081201

• [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20081201

• Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.

  Cancer 20081101

• The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.

  BJU international 20081101

• Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice.

  Current oncology reports 20081101

• Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

  European journal of endocrinology 20081101

• Association between 5-alpha reductase inhibition and risk of hip fracture.

  JAMA 20081008

• Can weight loss prevent cancer?

  British journal of cancer 20081007

• [Conservative treatment of benign prostatic hyperplasia].

  Orvosi hetilap 20081005

• Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.

  Diabetes 20081001

• Medical treatments for male and female pattern hair loss.

  Journal of the American Academy of Dermatology 20081001

• Expression of E-SOD, GPX5 mRNAs and immunoexpression of Cu/ZnSOD in epididymal epithelial cells of finasteride-treated rats.

  Andrologia 20081001

• A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.

  International journal of clinical practice 20081001

• New study makes case for prostate cancer drug.

  ONS connect 20081001

• Does Proscar prevent prostate cancer?

  The Johns Hopkins medical letter health after 50 20081001

• Drug metabolism and pharmacokinetics.

  Indian journal of pharmacology 20081001

• Propecia-induced spermatogenic failure: a report of two cases.

  Fertility and sterility 20080901

• Ethanol intake patterns in female mice: influence of allopregnanolone and the inhibition of its synthesis.

  Drug and alcohol dependence 20080901

• Hair transplantation for men.

  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20080901

• Cancer is a preventable disease that requires major lifestyle changes.

  Pharmaceutical research 20080901

• How many drugs for LUTS due to BPH are too many?

  The Journal of urology 20080901

• Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.

  The Journal of urology 20080901

• In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.

  The Journal of steroid biochemistry and molecular biology 20080901

• In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.

  AAPS PharmSciTech 20080901

• A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia.

  Current urology reports 20080901

• Studies on neurosteroids XXV. Influence of a 5alpha-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism.

  Biological & pharmaceutical bulletin 20080901

• Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.

  Clinical interventions in aging 20080901

• Preventing prostate cancer: new analyses put finasteride back on the map.

  Journal of the National Cancer Institute 20080820

• Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL/6J mice.

  Alcoholism, clinical and experimental research 20080801

• Androgens and prostate cancer risk.

  Best practice & research. Clinical endocrinology & metabolism 20080801

• High-grade prostate cancer and the prostate cancer prevention trial.

  Cancer prevention research (Philadelphia, Pa.) 20080801

• Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

  Cancer prevention research (Philadelphia, Pa.) 20080801

• Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.

  Cancer prevention research (Philadelphia, Pa.) 20080801

• Estimating rates of true high-grade disease in the prostate cancer prevention trial.

  Cancer prevention research (Philadelphia, Pa.) 20080801

• Neonatal finasteride induces anxiogenic-like profile and deteriorates passive avoidance in adulthood after intrahippocampal neurosteroid administration.

  Neuroscience 20080717

• Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

  International journal of clinical practice 20080701

• Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.

  The Journal of urology 20080701

• The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride.

  Expert review of anticancer therapy 20080701

• By the way, doctor. I have been taking Avodart for my BPH, along with Flomax, but finasteride may be less expensive. Should I switch?

  Harvard health letter 20080701

• Finasteride for prevention of prostate cancer.

  The Medical letter on drugs and therapeutics 20080630

• Olanzapine counteracts stress-induced anxiety-like behavior in rats.

  Neuroscience letters 20080620

• The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.

  The Journal of urology 20080601

• Androgens and prevention of prostate cancer.

  Current opinion in endocrinology, diabetes, and obesity 20080601

• A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis.

  Journal of proteome research 20080601

• Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice.

  Andrologia 20080601

• Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.

  Journal of Korean medical science 20080601

• Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.

  The New England journal of medicine 20080515

• Voltammetric reduction of finasteride at mercury electrode and its determination in tablets.

  Talanta 20080515

• A systematic review of commonly used medical treatments for hirsutism in women.

  Clinical endocrinology 20080501

• Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABA A-related mechanistic probes.

  Psychopharmacology 20080501

• Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial.

  Urology 20080501

• Open to debate. The Motion: all men over the age of 50 should be encouraged to take a 5alpha-reductase inhibitor to prevent prostate cancer.

  European urology 20080501

• Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.

  The British journal of dermatology 20080501

• A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.

  European journal of cancer (Oxford, England : 1990) 20080501

• Prostate cancer update: 2007.

  Current opinion in oncology 20080501

• Does the level of prostate cancer risk affect cancer prevention with finasteride?

  Urology 20080501

• [Hair follicle regeneration].

  Nihon rinsho. Japanese journal of clinical medicine 20080501

• Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report.

  Pharmacopsychiatry 20080501

• 5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives.

  The American journal of managed care 20080501

• Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.

  The American journal of managed care 20080501

• Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men.

  The American journal of managed care 20080501

• Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.

  The American journal of managed care 20080501

• [Clinical evaluation on fengweicao granule in treating benign prostatic hyperplasia].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080501

• Different patterns of 5alpha-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells.

  Biochemical and biophysical research communications 20080418

• Five-alpha-reductase Inhibitors for prostate cancer prevention.

  The Cochrane database of systematic reviews 20080416

• Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

  American journal of epidemiology 20080415

• Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice.

  Pharmacology, biochemistry, and behavior 20080401

• Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.

  The Journal of clinical endocrinology and metabolism 20080401

• The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.

  The Journal of urology 20080401

• Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.

  Chemical research in toxicology 20080401

• The Prostate Cancer Prevention Trial and the future of chemoprevention.

  BJU international 20080401

• Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line.

  International journal of oncology 20080401

• Development and validation of an LC-MS assay for finasteride and its application to prostate cancer prevention trial sample analysis.

  Journal of chromatographic science 20080401

• Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate.

  Indian journal of medical sciences 20080401

• [The PCPT trial].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• [PCPT trial: expected bias and their management].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• [The pathologist's perspective on the PCPT trial].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• [Relevance of chemoprevention from PCPT trial].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080401

• Androgen deprivation therapy for precancerous lesions of the prostate.

  Best practice & research. Clinical endocrinology & metabolism 20080401

• 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.

  Best practice & research. Clinical endocrinology & metabolism 20080401

• Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome.

  Therapeutics and clinical risk management 20080401

• Leuprorelin depot injection: patient considerations in the management of prostatic cancer.

  Therapeutics and clinical risk management 20080401

• A review of hormonal therapy for female pattern (androgenic) alopecia.

  Dermatology online journal 20080315

• Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.

  Cancer 20080301

• Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids.

  Journal of molecular neuroscience : MN 20080301

• Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer?

  Nature clinical practice. Urology 20080301

• FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.

  American family physician 20080301

• Role of hormonal and other factors in human prostate cancer.

  Journal of toxicology and environmental health. Part B, Critical reviews 20080301

• Testosterone for the aging male; current evidence and recommended practice.

  Clinical interventions in aging 20080301

• Finasteride therapy for benign prostatic hyperplasia.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080226

• Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.

  The Prostate 20080215

• Treatment of chronic prostatitis/chronic pelvic pain syndrome.

  International journal of antimicrobial agents 20080201

• Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

  European urology 20080201

• Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice.

  Journal of neurochemistry 20080201

• Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockers.

  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20080201

• Androgen therapy and atherosclerotic cardiovascular disease.

  Vascular health and risk management 20080201

• Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.

  Therapeutics and clinical risk management 20080201

• Inhibitory effect of traditional Chinese medicine Zi-Shen Pill on benign prostatic hyperplasia in rats.

  Journal of ethnopharmacology 20080117

• Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

  The Journal of urology 20080101

• Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey.

  International journal of clinical practice 20080101

• Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.

  Urologia internationalis 20080101

• Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.

  BMC urology 20080101

• The effect of finasteride on spermatogenesis of Mesocricetus auratus.

  Acta cirurgica brasileira 20080101

• Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).

  European journal of dermatology : EJD 20080101

• Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.

  European journal of dermatology : EJD 20080101

• A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

  BMC medicine 20080101

• Cancer chemoprevention: a summary of the current evidence.

  Anticancer research 20080101

• [Finasteride preoperative preparation of patients with prostatic adenoma to transurethral prostatic resection].

  Urologiia (Moscow, Russia : 1999) 20080101

• Androgen regulation of the androgen receptor coregulators.

  BMC cancer 20080101

• An open label, dose response study to determine the effect of a dietary supplement on dihydrotestosterone, testosterone and estradiol levels in healthy males.

  Journal of the International Society of Sports Nutrition 20080101

• Hypersensitivity to intravenous ondansetron: a case report.

  Journal of medical case reports 20080101

• Frailty Intervention Trial (FIT).

  BMC geriatrics 20080101

• A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.

  PloS one 20080101

• The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride.

  International braz j urol : official journal of the Brazilian Society of Urology 20080101

• Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals.

  European journal of drug metabolism and pharmacokinetics 20080101

• Histologic influence of doxazosin and finasteride in benign prostatic hyperplasia accompanying chronic inflammation.

  Urologia internationalis 20080101

• Selective androgen receptor modulators in preclinical and clinical development.

  Nuclear receptor signaling 20080101

• [Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma].

  Urologiia (Moscow, Russia : 1999) 20080101

• [Basic fibroblast growth factor as a prognostic factor of medication efficacy by meanes of prostatic adenoma].

  Urologiia (Moscow, Russia : 1999) 20080101

• Strategies for prostate cancer prevention: Review of the literature.

  Indian journal of urology : IJU : journal of the Urological Society of India 20080101

• 5-alpha-reductase and the development of the human prostate.

  Indian journal of urology : IJU : journal of the Urological Society of India 20080101

• Evaluation of the relationship between androgenetic alopecia and demodex infestation.

  Indian journal of dermatology 20080101

• A review of modern surgical hair restoration techniques.

  Journal of cutaneous and aesthetic surgery 20080101

• Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats.

  Brain research 20071212

• Prostate volume and adverse prostate cancer features: fact not artifact.

  European journal of cancer (Oxford, England : 1990) 20071201

• Intraoperative floppy-iris syndrome and finasteride intake.

  Journal of cataract and refractive surgery 20071201

• Treatment of Tourette's syndrome with finasteride.

  The American journal of psychiatry 20071201

• Managing prostate cancer: the role of hormone therapy.

  The Canadian journal of urology 20071201

• Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor.

  Environmental health perspectives 20071201

• Statistical power considerations show the endocrine disruptor low-dose issue in a new light.

  Environmental health perspectives 20071201

• Testosterone replacement therapy for older men.

  Clinical interventions in aging 20071201

• The many faces of testosterone.

  Clinical interventions in aging 20071201

• Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?

  The journal of sexual medicine 20071101

• Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design.

  Contemporary clinical trials 20071101

• The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.

  The Journal of urology 20071101

• Prostate cancer prevention: past, present, and future.

  Cancer 20071101

• [Diagnostic and therapeutic assessment of frontal fibrosing alopecia].

  Actas dermo-sifiliograficas 20071101

• Mechanism of salutary effects of finasteride on post-traumatic immune/inflammatory response: upregulation of estradiol synthesis.

  Annals of surgery 20071101

• Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?

  Urology 20071101

• Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility.

  Pharmacology, biochemistry, and behavior 20071001

• 3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1.

  Bioorganic & medicinal chemistry letters 20071001

• [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].

  Der Urologe. Ausg. A 20071001

• GABAergic neurosteroids mediate the effects of ethanol on long-term potentiation in rat hippocampal slices.

  The European journal of neuroscience 20071001

• Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.

  The Canadian journal of urology 20071001

• High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact?

  Journal of the National Cancer Institute 20070919

• Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.

  Journal of the National Cancer Institute 20070919

• Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

  Journal of the National Cancer Institute 20070919

• Preparation of novel polymeric microspheres for controlled release of finasteride.

  International journal of pharmaceutics 20070905

• Chemoprevention of prostate cancer: agents and study designs.

  The Journal of urology 20070901

• PKC activation sets an upper limit to the functional plasticity of GABAergic transmission induced by endogenous neurosteroids.

  The European journal of neuroscience 20070901

• Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.

  Urology 20070901

• The osteoporotic male: overlooked and undermanaged?

  Clinical interventions in aging 20070901

• [Benign prostatic hyperplasia: medical therapy].

  MMW Fortschritte der Medizin 20070816

• Dose-response effect of Red Maca (Lepidium meyenii) on benign prostatic hyperplasia induced by testosterone enanthate.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20070801

• Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase.

  American journal of physiology. Endocrinology and metabolism 20070801

• Common causes of male dog infertility.

  Theriogenology 20070801

• The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes.

  Chemistry and physics of lipids 20070801

• Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?

  Nature clinical practice. Urology 20070801

• GhDET2, a steroid 5alpha-reductase, plays an important role in cotton fiber cell initiation and elongation.

  The Plant journal : for cell and molecular biology 20070801

• 5alpha-reductase inhibition for men with enlarged prostate.

  Journal of the American Academy of Nurse Practitioners 20070801

• Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.

  Prescrire international 20070801

• Current treatment options in the management of chronic prostatitis.

  Therapeutics and clinical risk management 20070801

• Finasteride for chemoprevention of prostate cancer: why has it not been embraced?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070720

• Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070720

• Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats.

  European journal of pharmacology 20070719

• The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum.

  Bioorganic & medicinal chemistry 20070715

• [Comparison of different drugs on the treatment of benign prostate hyperplasia].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20070715

• Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

  Journal of the National Cancer Institute 20070704

• A new spectrophotometric method for the determination of finasteride in tablets.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070701

• Finasteride decreases the risk of prostatic intraepithelial neoplasia.

  The Journal of urology 20070701

• Re: expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. T. Kurahashi, H. Miyake, I. Hara and M. Fujisawa J Urol 2007; 177: 757-761.

  The Journal of urology 20070701

• Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.

  Current medical research and opinion 20070701

• Chemoprevention of prostate cancer: lessons learned.

  BJU international 20070701

• Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men.

  Environmental health perspectives 20070701

• Comparison of efficacy between Tamsulosin and Finasteride on symptomatic Benign Prostatic Hyperplasia.

  Mymensingh medical journal : MMJ 20070701

• [The establishment of hypospadias rat model and embryoteratogenic test of Atrazine].

  Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery 20070701

• Advances in the medical management of benign prostatic hyperplasia.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20070619

• Inhibition of neurosteroid synthesis increases asphyxia-induced brain injury in the late gestation fetal sheep.

  Neuroscience 20070608

• Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20070601

• [Chemoprevention of prostate cancer. Current status].

  Der Urologe. Ausg. A 20070601

• Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling.

  The Journal of urology 20070601

• The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites.

  The Journal of endocrinology 20070601

• Androgenetic alopecia.

  Endocrinology and metabolism clinics of North America 20070601

• Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.

  Expert opinion on pharmacotherapy 20070601

• Female pattern hair loss: current treatment concepts.

  Clinical interventions in aging 20070601

• Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice.

  Neuroscience 20070525

• Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20070501

• The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.

  The Journal of clinical endocrinology and metabolism 20070501

• Prostate cancer update: 2006.

  Current opinion in oncology 20070501

• Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat.

  Hormones and behavior 20070501

• Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.

  The Journal of urology 20070501

• Structural study of polymorphs and solvates of finasteride.

  Journal of pharmaceutical sciences 20070501

• Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.

  International journal of urology : official journal of the Japanese Urological Association 20070501

• The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies.

  Environmental health perspectives 20070501

• Benign prostatic hyperplasia: when to 'watch and wait,' when and how to treat.

  Cleveland Clinic journal of medicine 20070501

• Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070401

• Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells.

  Toxicology in vitro : an international journal published in association with BIBRA 20070401

• A woman with iatrogenic androgenetic alopecia responding to finasteride.

  The British journal of dermatology 20070401

• A review of phase III clinical trials of prostate cancer chemoprevention.

  Annals of the Royal College of Surgeons of England 20070401

• Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.

  Therapeutic drug monitoring 20070401

• [Effectiveness of the treatment plan for androgenetic alopecia].

  Georgian medical news 20070401

• Erythema annulare centrifugum secondary to treatment with finasteride.

  Journal of drugs in dermatology : JDD 20070401

• A rapid, simple, specific liquid chromatographic-electrospray mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic study.

  Journal of pharmaceutical and biomedical analysis 20070312

• Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.

  European journal of cancer (Oxford, England : 1990) 20070301

• The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.

  The Journal of urology 20070301

• Effect of two different extracts of red maca in male rats with testosterone-induced prostatic hyperplasia.

  Asian journal of andrology 20070301

• Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070301

• A review of combination therapy in patients with benign prostatic hyperplasia.

  Clinical therapeutics 20070301

• Update on the use of dutasteride in the management of benign prostatic hypertrophy.

  Clinical interventions in aging 20070301

• Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution).

  Clinical interventions in aging 20070301

• Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH).

  Therapeutics and clinical risk management 20070301

• PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice.

  Canadian Urological Association journal = Journal de l'Association des urologues du Canada 20070301

• Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20070227

• Medical therapy for benign prostatic hyperplasia--present and future impact.

  The American journal of managed care 20070201

• A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.

  The American journal of managed care 20070201

• Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs.

  The American journal of managed care 20070201

• Finasteride versus dutasteride: a real-world economic evaluation.

  The American journal of managed care 20070201

• Medical treatment of benign prostatic hyperplasia.

  Postgraduate medical journal 20070201

• Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20070201

• Evolution of techniques in hair transplantation: a 12-year perspective.

  Facial plastic surgery : FPS 20070201

• Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?

  Molecular interventions 20070201

• Hormone ablation therapy: lightening the load for today's prostate cancer patient.

  Urologic nursing 20070201

• Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis.

  British journal of cancer 20070129

• Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas.

  Cancer research 20070115

• Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones.

  International journal of pharmaceutics 20070110

• Social isolation stress and neuroactive steroids.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070101

• The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries.

  European urology 20070101

• Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention.

  European urology 20070101

• The prostate cancer prevention trial and its messages.

  European urology 20070101

• Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma.

  Histology and histopathology 20070101

• Effect of finasteride on prostate-specific antigen.

  The Lancet. Oncology 20070101

• Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.

  The Lancet. Oncology 20070101

• A pilot study on acupuncture for lower urinary tract symptoms related to chronic prostatitis/chronic pelvic pain.

  Chinese medicine 20070101

• A favorable view: progress in cancer prevention and screening.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20070101

• Prevention of prostate cancer: more questions than data.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20070101

• Finasteride to evaluate the efficacy of dutasteride in the management of patients with lower urinary tract symptoms and enlarged prostate.

  Archives of andrology 20070101

• Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials.

  BMC medicine 20070101

• A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

  Clinical therapeutics 20070101

• Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.

  Prostate cancer and prostatic diseases 20070101

• Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway.

  Scandinavian journal of urology and nephrology 20070101

• Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.

  Prostate cancer and prostatic diseases 20070101

• Method for evaluating prediction models that apply the results of randomized trials to individual patients.

  Trials 20070101

• Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.

  Journal of andrology 20070101

• Identification of the patient with enlarged prostate: diagnosis and guidelines for management.

  Osteopathic medicine and primary care 20070101

• Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model.

  The Journal of steroid biochemistry and molecular biology 20070101

• Can a single model explain both breast cancer and prostate cancer?

  Theoretical biology & medical modelling 20070101

• Spermatozoa and chronic treatment with finasteride: a TEM and FISH study.

  Archives of andrology 20070101

• Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.

  BMC health services research 20070101

• [The fibroblast growth factor as a predictor of symptomatic change under combined pharmacological treatment of benign prostatic hyperplasia].

  Georgian medical news 20070101

• Rat epididymal epithelial cells and 17beta-estradiol synthesis under hCG stimulation in vitro.

  Folia histochemica et cytobiologica 20070101

• Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.

  Pharmaceutical development and technology 20070101

• Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Application of evidence-based urology in improving quality of care.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Evaluating systematic reviews in urology: A practical guide.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Neurosteroids involved in regulating inhibition in the inferior colliculus.

  Journal of neurophysiology 20061201

• Re: The Prostate Cancer Prevention Trial: design, biases and interpretation of study results. P. J. Goodman, I. M. Thompson, Jr., C. M. Tangen, J. J. Crowley, L. G. Ford and C. A. Coltman, Jr., J Urol, 175: 2234-2242, 2006.

  The Journal of urology 20061201

• The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.

  Journal of the American Academy of Dermatology 20061201

• Prostate cancer risk in testosterone-treated men.

  The Journal of steroid biochemistry and molecular biology 20061201

• The effectiveness of a treatment protocol for male lower urinary tract symptoms in general practice: a practical randomised controlled trial.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20061201

• Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?

  Urology 20061201

• Comorbid LUTS and erectile dysfunction: optimizing their management.

  Current medical research and opinion 20061201

• Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201

• New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20061201

• Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior.

  Dialogues in clinical neuroscience 20061201

• Doxazosin in the treatment of benign prostatic hypertrophy: an update.

  Clinical interventions in aging 20061201

• Role of 5 alpha-reductase inhibitors in the management of prostate cancer.

  Clinical interventions in aging 20061201

• Protein profiling of rat ventral prostate following chronic finasteride administration: identification and localization of a novel putative androgen-regulated protein.

  Molecular & cellular proteomics : MCP 20061101

• Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese.

  European journal of clinical pharmacology 20061101

• Prostate cancer prevention and finasteride.

  The Journal of urology 20061101

• Dynamic contrast enhanced magnetic resonance imaging as a biological marker to noninvasively assess the effect of finasteride on prostatic suburethral microcirculation.

  The Journal of urology 20061101

• The evolution of the PCPT from clinical to molecular analyses.

  Nature clinical practice. Oncology 20061101

• Female-patterned alopecia in teenage brothers with unusual histologic features.

  Journal of cutaneous pathology 20061101

• Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation.

  The European journal of neuroscience 20061101

• The anxiolytic effect of pregnancy in rats is reversed by finasteride.

  Pharmacology, biochemistry, and behavior 20061101

• Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia.

  Yonsei medical journal 20061031

• Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.

  International journal of pharmaceutics 20061012

• Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: a review.

  Theriogenology 20061001

• Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.

  Experimental neurology 20061001

• Changes in expression of the delta subunit of the GABA (A) receptor and in receptor function induced by progesterone exposure and withdrawal.

  Journal of neurochemistry 20061001

• A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil.

  International journal of clinical practice 20061001

• The population dynamics of cancer: a Darwinian perspective.

  International journal of epidemiology 20061001

• Chemoprevention in prostate cancer.

  Pharmacotherapy 20061001

• Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20061001

• Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.

  BMJ (Clinical research ed.) 20060923

• Benign prostatic hypertrophy: update on drug therapy.

  Canadian family physician Medecin de famille canadien 20060910

• The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.

  The Journal of urology 20060901

• Should finasteride be used to prevent prostate cancer?

  Current treatment options in oncology 20060901

• Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.

  Nature clinical practice. Urology 20060901

• Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.

  The Journal of endocrinology 20060901

• [Drug therapy for benign prostatic syndrome (BPS)].

  Aktuelle Urologie 20060901

• New finasteride trial results aim to curb controversy.

  Journal of the National Cancer Institute 20060816

• Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

  Journal of the National Cancer Institute 20060816

• Deoxycorticosterone's anticonvulsant effects in infant rats are blocked by finasteride, but not by indomethacin.

  Experimental neurology 20060801

• Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.

  The Prostate 20060801

• Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective.

  Journal of neurobiology 20060801

• Further errors in polymorph identification: furosemide and finasteride.

  Acta crystallographica. Section B, Structural science 20060801

• The cost of prostate cancer chemoprevention: a decision analysis model.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20060801

• Deiodinase type 1 activity is expressed in the prostate of pubescent rats and is modulated by thyroid hormones, prolactin and sex hormones.

  The Journal of endocrinology 20060801

• Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.

  Nature clinical practice. Urology 20060801

• Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.

  Urology 20060801

• Plastic neuronal changes in GABA(A) receptor gene expression induced by progesterone metabolites: in vitro molecular and functional studies.

  Pharmacology, biochemistry, and behavior 20060801

• New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth.

  Journal of enzyme inhibition and medicinal chemistry 20060801

• Benign prostatic hyperplasia (BPH).

  Harvard men's health watch 20060801

• Finasteride delays the onset of maternal behavior in primigravid rats.

  Physiology & behavior 20060730

• Re: Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial.

  The Journal of urology 20060701

• Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.

  Journal of the American Academy of Dermatology 20060701

• Medicolegal aspects of doping in football.

  British journal of sports medicine 20060701

• Social isolation-induced increase in alpha and delta subunit gene expression is associated with a greater efficacy of ethanol on steroidogenesis and GABA receptor function.

  Journal of neurochemistry 20060701

• Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060701

• Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.

  Magnetic resonance imaging 20060701

• Lack of evidence of a role for the neurosteroid allopregnanolone in ethanol-induced reward and c-fos expression in DBA/2 mice.

  Brain research 20060613

• Determination of vinflunine in rat plasma by liquid chromatography-electrospray ionization mass spectrometry for a pharmacokinetic study.

  Journal of pharmaceutical and biomedical analysis 20060607

• Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder.

  Psychopharmacology 20060601

• Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats.

  Psychopharmacology 20060601

• Getting it right: being smarter about clinical trials.

  PLoS medicine 20060601

• The prostate cancer prevention trial: design, biases and interpretation of study results.

  The Journal of urology 20060601

• Perifollicular fibrosis: pathogenetic role in androgenetic alopecia.

  Biological & pharmaceutical bulletin 20060601

• Treatment of hirsutism and acne in hyperandrogenism.

  Best practice & research. Clinical endocrinology & metabolism 20060601

• Managing hair loss. Treatments may help.

  Mayo Clinic health letter (English ed.) 20060601

• [Pharmacological and clinical profile of finasteride (PROPECIA)].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20060601

• Pharmacologic interventions in aging hair.

  Clinical interventions in aging 20060601

• Actions of 5alpha-reductase inhibitors on the epididymis.

  Molecular and cellular endocrinology 20060516

• Development and validation of a new gas flame ionization detector method for the determination of finasteride in tablets.

  Analytical biochemistry 20060515

• Intermittent use of testosterone inactivating pharmaceuticals using finasteride prolongs the time off period.

  The Journal of urology 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Validation of scalp coverage scoring methods for scalp hair loss in male pattern hair loss (androgenetic alopecia).

  Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 20060501

• Chemoprevention of prostate cancer with finasteride.

  Expert opinion on pharmacotherapy 20060501

• An update on chemoprevention strategies in prostate cancer for 2006.

  Current opinion in urology 20060501

• Possible involvement of 5alpha-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells.

  Brain research 20060426

• Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

  Cancer 20060415

• Enhancement of intermittent androgen ablation by 'off-cycle' maintenance with finasteride in LNCaP prostate cancer xenograft model.

  The Prostate 20060401

• Impact of medical treatments for benign prostatic hyperplasia on sexual function.

  BJU international 20060401

• Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?

  BJU international 20060401

• Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.

  The Journal of urology 20060401

• Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.

  The British journal of dermatology 20060401

• Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia.

  The Annals of pharmacotherapy 20060401

• BPH: epidemiology and comorbidities.

  The American journal of managed care 20060401

• Treatment and pharmacologic management of BPH in the context of common comorbidities.

  The American journal of managed care 20060401

• BPH: costs and treatment outcomes.

  The American journal of managed care 20060401

• COMPRENDO: Focus and approach.

  Environmental health perspectives 20060401

• Use of the three-spined stickleback (Gasterosteus aculeatus) as a sensitive in vivo test for detection of environmental antiandrogens.

  Environmental health perspectives 20060401

• Reducing the 'risk' of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.

  Cancer research 20060315

• Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial?

  The Journal of urology 20060301

• Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia.

  The Journal of urology 20060301

• Update on prostate cancer chemoprevention.

  Pharmacotherapy 20060301

• Emerging drug therapies for benign prostatic hyperplasia.

  Expert opinion on emerging drugs 20060301

• Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

  Diabetes care 20060301

• Finasteride treatment of female pattern hair loss.

  Archives of dermatology 20060301

• Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines.

  Evidence-based complementary and alternative medicine : eCAM 20060301

• Lipedematous alopecia of the scalp.

  Dermatology online journal 20060227

• Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?

  International journal of cardiology 20060215

• Skin permeation of different steroid hormones from polymeric coated liposomal formulations.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060201

• Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5 alpha-reductase inhibitor.

  The Journal of steroid biochemistry and molecular biology 20060201

• Evidence for a biopsy derived grade artifact among larger prostate glands.

  The Journal of urology 20060201

• Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?

  Mayo Clinic proceedings 20060201

• Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.

  Journal of medicinal chemistry 20060126

• [Prostate cancer prevention].

  Revue medicale suisse 20060111

• Neuroactive steroids attenuate oxytocin stress responses in late pregnancy.

  Neuroscience 20060101

• Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study.

  European urology 20060101

• Disease versus disease: how one disease may ameliorate another.

  Pediatrics 20060101

• Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men.

  Journal of andrology 20060101

• Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.

  The Journal of urology 20060101

• By the way, doctor. I developed acute urinary retention after having a pacemaker put in. I'm a 90-year-old man and in pretty good shape considering my age, but I'd rather not have any more procedures. What are my options?

  Harvard health letter 20060101

• [Nutrition and pharmacological treatment for prevention of prostate cancer].

  Harefuah 20060101

• Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

  Clinical therapeutics 20060101

• Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia.

  Current pharmaceutical design 20060101

• [Prevalence of incidental prostatic adenocarcinoma after suprapubic adenomectomy with or without previous prostatic biopsy].

  Archivos espanoles de urologia 20060101

• Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.

  Cancer journal (Sudbury, Mass.) 20060101

• Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.

  Skin pharmacology and physiology 20060101

• Questionnaire survey of urologists' initial treatment practices for acute urinary retention secondary to benign prostatic hyperplasia in Korea.

  Urologia internationalis 20060101

• [Clinicopathological study of incidental cancer prostate in patients undergoing surgery for symptomatic diagnosis of BPH].

  Actas urologicas espanolas 20060101

• Diagnosis and management of polycystic ovary syndrome: a practical guide.

  Drugs 20060101

• A new look at the 5alpha-reductase inhibitor finasteride.

  CNS drug reviews 20060101

• Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate.

  International urology and nephrology 20060101

• Hormonal status of male reproductive system: androgens and estrogens in the testis and epididymis. In vivo and in vitro approaches.

  Reproductive biology 20060101

• Chemopreventive trials in urologic cancer.

  Reviews in urology 20060101

• Prevention, complementary therapies, and new scientific developments in the field of prostate cancer.

  Reviews in urology 20060101

• Finasteride induced depression: a prospective study.

  BMC clinical pharmacology 20060101

• Dropout in a longitudinal, cohort study of urologic disease in community men.

  BMC medical research methodology 20060101

• Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report.

  BMC cancer 20060101

• [Finasteride-induced hepatitis].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101

• [Treatment of prostatic adenoma patients with inhibitor of 5-alpha-reductase of type I and II avodart (dutasteride)].

  Urologiia (Moscow, Russia : 1999) 20060101

• Increasing the availability of generics.

  FDA consumer 20060101

• Repetitive prostatic massage and drug therapy as an alternative to transurethral resection of the prostate.

  MedGenMed : Medscape general medicine 20060101

• [Using doxasosine and finasteride combination in the treatment of prostate adenoma].

  Urologiia (Moscow, Russia : 1999) 20060101

• [Epididymis in an experimental model of DHT deficiency: immunolocalization of ERalpha and ERbeta in rat epididymal epithelial cells. In vivo and in vitro studies].

  Annales Academiae Medicae Stetinensis 20060101

• A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol (5alpha-androstane-3alpha,17beta-diol) in plasma.

  Steroids 20051201

• The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.

  The Journal of urology 20051201

• Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks.

  BJU international 20051201

• Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss.

  Acta oto-laryngologica 20051201

• Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome.

  Evidence-based complementary and alternative medicine : eCAM 20051201

• Synthesis and pharmacological evaluation of new progesterone esters as 5alpha-reductase inhibitors.

  Chemical & pharmaceutical bulletin 20051201

• Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism.

  The journal of investigative dermatology. Symposium proceedings 20051201

• The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain.

  Pharmacology, biochemistry, and behavior 20051201

• The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.

  Epilepsia 20051201

• [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20051201

• Polycystic ovary syndrome.

  Clinical evidence 20051201

• [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20051201

• Finasteride and minoxidil for alopecia revisited.

  The Medical letter on drugs and therapeutics 20051121

• Phase III prostate cancer prevention trials: are the costs justified?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110

• In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure.

  International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20051101

• The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).

  BJU international 20051101

• Frontal fibrosing alopecia: a survey in 16 patients.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20051101

• Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.

  Urology 20051101

• Immunolocalization of androgen receptor in the epididymis of rats with dihydrotestosterone deficiency.

  Reproductive biology 20051101

• The evaluation and treatment of hirsute women.

  Women's health (London, England) 20051101

• Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020

• Rebalancing ratios and improving impressions: later thoughts from the prostate cancer prevention trial investigators.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020

• Estimated impact of the prostate cancer prevention trial on population mortality.

  Cancer 20051001

• Effects of finasteride (1 mg) on hair transplant.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20051001

• Psychological effect, pathophysiology, and management of androgenetic alopecia in men.

  Mayo Clinic proceedings 20051001

• Evaluation and medical management of benign prostatic hyperplasia.

  Mayo Clinic proceedings 20051001

• Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects.

  Urology 20051001

• Determination method for steroid 5alpha-reductase activity using liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20051001

• [Finasteride--ris of 'unintentional doping'].

  Lakartidningen 20051001

• [Prevention of prostate cancer].

  Deutsche medizinische Wochenschrift (1946) 20050909

• New approach to 3-oxo-4-aza-5alpha-androst-1-ene-17beta-(N-tert-butylcarboxamide).

  Steroids 20050901

• The ontogeny of the urogenital system of the spotted hyena (Crocuta crocuta Erxleben).

  Biology of reproduction 20050901

• The finasteride prostate cancer prevention trial (PCPT)--what have we learned?

  European journal of cancer (Oxford, England : 1990) 20050901

• Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

  The Journal of urology 20050901

• Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus.

  Journal of neuroendocrinology 20050901

• 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: reproductive aspects.

  Pharmacology, biochemistry, and behavior 20050901

• [Effect of large-dosage of 5alpha-reductase inhibitors on the spermatogenesis of male rats].

  Zhonghua nan ke xue = National journal of andrology 20050901

• [Novel therapeutics strategies in benign hypertrophy of prostate management].

  Revue medicale de Bruxelles 20050901

• [Analysis of the scientific evidence of the combination therapy in benign prostatic hyperplasia].

  Actas urologicas espanolas 20050901

• Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.

  European urology 20050801

• Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.

  BJU international 20050801

• Decrease in anogenital distance among male infants with prenatal phthalate exposure.

  Environmental health perspectives 20050801

• Effects of environmental agents on the attainment of puberty: considerations when assessing exposure to environmental chemicals in the National Children's Study.

  Environmental health perspectives 20050801

• Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.

  The American journal of medicine 20050801

• [5alpha-dihydrotestosterone (DHT)].

  Nihon rinsho. Japanese journal of clinical medicine 20050801

• Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?

  Alcohol (Fayetteville, N.Y.) 20050801

• Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.

  Bangladesh Medical Research Council bulletin 20050801

• Clinical trials point to complexities of chemoprevention for cancer.

  JAMA 20050706

• Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.

  Psychopharmacology 20050701

• Acute urinary retention in men: the risks and outcomes with medical therapy.

  Current urology reports 20050701

• Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.

  Current urology reports 20050701

• Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome.

  Current urology reports 20050701

• Effect of androgen concentration on seminal vesicle blood flow in rats-establishment of new highly sensitive simultaneous androgen measurement method.

  Urology 20050701

• Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.

  Cancer 20050615

• [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray].

  Zhonghua yi xue za zhi 20050608

• GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050601

• A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.

  The Journal of urology 20050601

• A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.

  The Journal of urology 20050601

• Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

  European urology 20050601

• Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.

  Journal of molecular endocrinology 20050601

• Bayesian analysis of multicentre trial outcomes.

  Statistical methods in medical research 20050601

• Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines.

  Alcoholism, clinical and experimental research 20050601

• Prostate cancer: chemoprevention update 2005.

  The Canadian journal of urology 20050601

• [Is tumour grade applicable to finasteride-treated prostate cancer?].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20050601

• Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

  The American journal of geriatric pharmacotherapy 20050601

• Hair transplantation: new concepts in 2005.

  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 20050601

• Aging of hair.

  Journal of cosmetic dermatology 20050601

• Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.

  The Prostate 20050515

• Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1.

  Journal of cellular biochemistry 20050501

• Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.

  Nature clinical practice. Oncology 20050501

• Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.

  Journal of medicinal chemistry 20050421

• Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050420

• Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.

  Journal of cancer research and clinical oncology 20050401

• Estimated impact of the Prostate Cancer Prevention Trial on population mortality.

  Cancer 20050401

• Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator (SARM), the 5alpha-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia (BPH).

  The Journal of urology 20050401

• RE: Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.

  The Journal of urology 20050401

• Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats.

  Neuropharmacology 20050401

• Hidradenitis suppurativa treated with finasteride.

  The Journal of dermatological treatment 20050401

• Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

  International journal of cancer 20050320

• Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050320

• Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

  The Journal of clinical endocrinology and metabolism 20050301

• Preliminary study on androgen dependence of calcitonin gene-related peptide in rat penis.

  Asian journal of andrology 20050301

• Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.

  BJU international 20050301

• The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.

  BJU international 20050301

• Attenuating 5alpha-pregnane-3alpha-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures.

  Epilepsy & behavior : E&B 20050301

• A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).

  The Journal of urology 20050301

• The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the proscar long-term efficacy and safety study.

  The Journal of urology 20050301

• Finasteride with doxazosin to reduce BPH progression.

  The Nurse practitioner 20050301

• New 5alpha-reductase inhibitors: in vitro and in vivo effects.

  Steroids 20050301

• Androgenetic alopecia and current methods of treatment.

  Acta dermatovenerologica Alpina, Pannonica, et Adriatica 20050301

• Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer.

  Clinical prostate cancer 20050301

• Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice.

  Brain research 20050201

• Evaluation and treatment of male and female pattern hair loss.

  Journal of the American Academy of Dermatology 20050201

• [Prostate cancer. Introduction].

  Nihon rinsho. Japanese journal of clinical medicine 20050201

• [Risk factors and current chemoprevention studies in prostate cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20050201

• Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.

  International journal of urology : official journal of the Japanese Urological Association 20050201

• Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia.

  Expert opinion on pharmacotherapy 20050201

• Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.

  The Canadian journal of urology 20050201

• [Urology. Benign prostatic hyperplasia].

  Revue medicale suisse 20050112

• Prevention of hormone-related cancers: prostate cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050110

• Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.

  American journal of physiology. Endocrinology and metabolism 20050101

• Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia.

  The Journal of clinical endocrinology and metabolism 20050101

• Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

  European urology 20050101

• Chemoprevention using dutasteride: the REDUCE trial.

  Current opinion in urology 20050101

• Role of phytotherapy in men with lower urinary tract symptoms.

  Current opinion in urology 20050101

• Proscar and Propecia--a therapeutic perspective.

  The Journal of urology 20050101

• Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones.

  Journal of neurochemistry 20050101

• Anxiolytic activity of progesterone in progesterone receptor knockout mice.

  Neuropharmacology 20050101

• Frontal fibrosing alopecia in postmenopausal women.

  Journal of the American Academy of Dermatology 20050101

• Two for the price of one?

  British journal of pharmacology 20050101

• Innovative agents in cancer prevention.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20050101

• Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.

  Urology 20050101

• [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].

  Zhonghua nan ke xue = National journal of andrology 20050101

• Pre-surgical finasteride therapy in patients treated endoscopically for benign prostatic hyperplasia.

  Urologia internationalis 20050101

• Propecia: the goose that lays the golden eggs.

  Skinmed 20050101

• Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies.

  BMC genetics 20050101

• Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.

  Current medicinal chemistry 20050101

• Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.

  Urologia internationalis 20050101

• Bioequivalence study of two different coated tablet formulations of finasteride in healthy volunteers.

  Arzneimittel-Forschung 20050101

• Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.

  Prostate cancer and prostatic diseases 20050101

• Impact of finasteride treatment on perioperative bleeding before transurethral resection of the prostate: a prospective randomized study.

  Scandinavian journal of urology and nephrology 20050101

• Noninvasive management of lower urinary tract symptoms and sexual dysfunction associated with benign prostatic hyperplasia in the primary care setting.

  Comprehensive therapy 20050101

• Effective treatment of female androgenic alopecia with dutasteride.

  Journal of drugs in dermatology : JDD 20050101

• Pharmacological profile of 9,11-dehydrocortexolone 17alpha-butyrate (CB-03-04), a new androgen antagonist with antigonadotropic activity.

  Arzneimittel-Forschung 20050101

• Can prostate cancer be prevented?

  Nature clinical practice. Urology 20050101

• [Prostate carcinoma: can 5-alpha reductase inhibitors prevent it?].

  Krankenpflege Journal 20050101

• [Prostate cancer chemoprevention].

  Przeglad lekarski 20050101

• Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.

  Reviews in urology 20050101

• A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.

  Reviews in urology 20050101

• Acute urinary retention: risks and management.

  Reviews in urology 20050101

• Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia.

  Core evidence 20050101

• Estrogen receptor beta in prostate cancer.

  The New England journal of medicine 20041223

• The effects of androgen depletion on human erectile function: a prospective study in male-to-female transsexuals.

  International journal of impotence research 20041201

• Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

  Endocrinology 20041201

• Re: inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale.

  The Journal of urology 20041201

• Testosterone therapy in the ageing male: what about the prostate?

  Andrologia 20041201

• Proscar and propecia--a therapeutic perspective.

  The Journal of clinical endocrinology and metabolism 20041201

• Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.

  BJU international 20041201

• [The PCPT study: the viewpoint of an urologist involved].

  Annales d'urologie 20041201

• [Use of 5-alpha-reductase inhibitors in the prevention of prostate cancer].

  Annales d'urologie 20041201

• Polycystic ovary syndrome.

  Clinical evidence 20041201

• In the adult CNS, ethanol prevents rather than produces NMDA antagonist-induced neurotoxicity.

  Brain research 20041126

• Patients with a large prostate show a higher prevalence of androgenetic alopecia.

  Archives of dermatological research 20041101

• [Newborn with bladder extrophy associated with finasteride exposure].

  Anales de pediatria (Barcelona, Spain : 2003) 20041101

• MTOPS: conclusions about invasive therapy for BPH should be interpreted with caution.

  BJU international 20041101

• [Pathomechanism of androgenetic alopecia and new treatment].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20041101

• The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

  The Journal of steroid biochemistry and molecular biology 20041101

• Effects of finasteride on prostate volume and prostate-specific antigen.

  Journal of the Chinese Medical Association : JCMA 20041101

• Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.

  Brain research 20041008

• Despite positive studies, popularity of chemoprevention drugs increasing slowly.

  Journal of the National Cancer Institute 20041006

• Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice.

  Psychopharmacology 20041001

• Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

  The Journal of urology 20041001

• Hirsutism and acne in polycystic ovary syndrome.

  Best practice & research. Clinical obstetrics & gynaecology 20041001

• Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20041001

• Effects of finasteride on the morphology of polycystic ovaries.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20041001

• Uropharmacology: current and future strategies in the treatment of erectile dysfunction and benign prostate hyperplasia.

  International journal of clinical pharmacology and therapeutics 20041001

• Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model.

  The Journal of steroid biochemistry and molecular biology 20041001

• [System review of the Chinese medicine bushenhuoxue for treating benign prostatic hyperplasia].

  Zhonghua nan ke xue = National journal of andrology 20041001

• Evaluation of cell permeation of a potent 5alpha-reductase inhibitor using MALDI-TOF MS.

  Journal of enzyme inhibition and medicinal chemistry 20041001

• Selective and rapid liquid chromatography-tandem mass spectrometry assay of dutasteride in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040925

• Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.

  Oncogene 20040923

• Effect of permixon on human prostate cell growth: lack of apoptotic action.

  The Prostate 20040915

• Benign prostate hyperplasia: evaluation of treatment response with DCE MRI.

  Magma (New York, N.Y.) 20040901

• Prevention of prostate cancer by androgens: experimental paradox or clinical reality.

  European urology 20040901

• Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.

  BJU international 20040901

• After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia.

  Expert opinion on pharmacotherapy 20040901

• Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

  Fertility and sterility 20040901

• [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].

  Aktuelle Urologie 20040901

• [Androgenetic alopecia].

  Revue medicale de Bruxelles 20040901

• The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia.

  Current urology reports 20040801

• The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

  Current urology reports 20040801

• The use of saw palmetto versus finasteride for the treatment of prostatitis/chronic pelvic pain syndrome.

  Current urology reports 20040801

• Combined modality treatment in the management of high-risk prostate cancer.

  International journal of radiation oncology, biology, physics 20040801

• Ethanol-induced elevation of 3 alpha-hydroxy-5 alpha-pregnan-20-one does not modulate motor incoordination in rats.

  Alcoholism, clinical and experimental research 20040801

• Finasteride-associated male infertility.

  Revista do Hospital das Clinicas 20040801

• An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.

  The Canadian journal of urology 20040801

• Dutasteride: a potent dual inhibitor of 5-alpha-reductase for benign prostatic hyperplasia.

  Drugs of today (Barcelona, Spain : 1998) 20040801

• Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20040721

• Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice.

  The Journal of pharmacology and experimental therapeutics 20040701

• Re: Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol 2003;44:650-5.

  European urology 20040701

• Meta-analysis: creating a level playing field for the patient with symptomatic benign prostatic hyperplasia?

  BJU international 20040701

• Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids.

  The Journal of endocrinology 20040701

• Proscar and propecia--a therapeutic perspective.

  The Journal of clinical endocrinology and metabolism 20040701

• Interaction of chronic ethanol exposure and finasteride: sex and strain differences.

  Pharmacology, biochemistry, and behavior 20040701

• 3alpha,5alpha-THP mediates progestins' effects to protect against adrenalectomy-induced cell death in the dentate gyrus of female and male rats.

  Pharmacology, biochemistry, and behavior 20040701

• Hippocampal 3alpha,5alpha-THP may alter depressive behavior of pregnant and lactating rats.

  Pharmacology, biochemistry, and behavior 20040701

• Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia.

  Archives of dermatology 20040701

• Finasteride (Propecia) and the promotion of high-grade prostate cancer.

  Archives of dermatology 20040701

• Relative safety and efficacy of finasteride for treatment of hirsutism.

  The Annals of pharmacotherapy 20040601

• The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.

  Oncology reports 20040601

• Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040601

• Recurrent macroscopic haematuria due to bladder blood vessels after exercise induced haematuria.

  British journal of sports medicine 20040601

• Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation.

  The Journal of endocrinology 20040601

• Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.

  Environmental health perspectives 20040601

• Increased expression of the gene for the Y1 receptor of neuropeptide Y in the amygdala and paraventricular nucleus of Y1R/LacZ transgenic mice in response to restraint stress.

  Journal of neurochemistry 20040601

• Inhibition of 5-alpha-reductase activity induces stromal remodeling and smooth muscle de-differentiation in adult gerbil ventral prostate.

  Differentiation; research in biological diversity 20040601

• Preventing diseases of the prostate in the elderly using hormones and nutriceuticals.

  The aging male : the official journal of the International Society for the Study of the Aging Male 20040601

• Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

  The New England journal of medicine 20040527

• [Chemoprevention of prostate cancer].

  Der Urologe. Ausg. A 20040501

• Update on chemoprevention of prostate cancer.

  Current opinion in urology 20040501

• Advances in prostate cancer.

  Current opinion in oncology 20040501

• 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.

  European urology 20040501

• Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20040501

• Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

  The Journal of clinical endocrinology and metabolism 20040501

• Pharmacologic management of pattern hair loss.

  Facial plastic surgery clinics of North America 20040501

• Two-drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice?

  BJU international 20040501

• A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).

  BJU international 20040501

• The clinical implications of the Prostate Cancer Prevention Trial (PCPT).

  BJU international 20040501

• Medical treatment regimens of hirsutism.

  Reproductive biomedicine online 20040501

• Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.

  Expert opinion on pharmacotherapy 20040501

• [Effect of finasteride on intraoperative bleeding and irrigating fluid absorption during transurethral resection of prostate: a quantitative study].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040501

• Implementation of the Prostate Cancer Prevention Trial (PCPT).

  Controlled clinical trials 20040401

• Testosterone-stimulated weanlings as an alternative to castrated male rats in the Hershberger anti-androgen assay.

  Regulatory toxicology and pharmacology : RTP 20040401

• Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.

  European journal of endocrinology 20040401

• Finasteride in the treatment of alopecia.

  Expert opinion on pharmacotherapy 20040401

• [Estimation of the cost in the medical treatment of benign prostatic hyperplasia in Navarre, Spain].

  Actas urologicas espanolas 20040401

• New aromatic esters of progesterone as antiandrogens.

  Journal of enzyme inhibition and medicinal chemistry 20040401

• Finasteride in benign prostatic hyperplasia.

  The New England journal of medicine 20040325

• Finasteride in benign prostatic hyperplasia.

  The New England journal of medicine 20040325

• Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.

  The Journal of urology 20040301

• A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.

  European journal of endocrinology 20040301

• [Effects of finasteride on capillary in the ventral prostate of rat].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20040301

• Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.

  Clinical prostate cancer 20040301

• Does finasteride alter the pathology of the prostate and cancer grading?

  Clinical prostate cancer 20040301

• Risk of acute pancreatitis in users of finasteride: a population-based case-control study.

  Journal of clinical gastroenterology 20040301

• An update on the use of 5alpha-reductase inhibitors.

  Drugs of today (Barcelona, Spain : 1998) 20040301

• Patients with bladder outlet obstruction who refuse treatment show no clinical and urodynamic change after long-term follow-up.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20040301

• Male breast cancer during finasteride therapy.

  Journal of the National Cancer Institute 20040218

• Effect of finasteride on risk of prostate cancer: how little we really know.

  Journal of cellular biochemistry 20040215

• Prostate cancer chemoprevention: an overview of United States trials.

  The Journal of urology 20040201

• Chemotherapeutic prevention studies of prostate cancer.

  The Journal of urology 20040201

• The Prostate Cancer Prevention Trial: current status.

  The Journal of urology 20040201

• Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.

  The Journal of urology 20040201

• Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.

  The Prostate 20040201

• Tailoring cancer chemoprevention regimens to the individual.

  Journal of cellular biochemistry 20040201

• Propecia-associated bilateral cataract.

  Clinical & experimental ophthalmology 20040201

• The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches.

  Pharmacology & therapeutics 20040201

• Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

  The Journal of clinical endocrinology and metabolism 20040201

• Herbal and vitamin supplement use in a prostate cancer screening population.

  Urology 20040201

• The treatment of polycystic ovary syndrome.

  Minerva ginecologica 20040201

• Hair loss remedies--separating fact from fiction.

  Cutis 20040201

• A current review of medical therapy for benign prostatic hyperplasia.

  The Journal of the American Osteopathic Association 20040201

• Production of 5alpha-reduced neurosteroids is developmentally regulated and shapes GABA(A) miniature IPSCs in lamina II of the spinal cord.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20040128

• Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.

  British journal of cancer 20040112

• A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

  The Journal of urology 20040101

• How do we investigate haematuria and what role has finasteride?

  BJU international 20040101

• Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men.

  Medical hypotheses 20040101

• Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens).

  Reproductive toxicology (Elmsford, N.Y.) 20040101

• [Finasteride and prostate cancer].

  Duodecim; laaketieteellinen aikakauskirja 20040101

• Who will benefit from combination therapy? The role of 5 alpha reductase inhibitors and alpha blockade: a reflection from MTOPS.

  Current opinion in urology 20040101

• Real life practice in the management of benign prostatic hyperplasia.

  Current opinion in urology 20040101

• Benign prostatic hyperplasia progression and its impact on treatment.

  Current opinion in urology 20040101

• Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone.

  ACP journal club 20040101

• The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies.

  Urologic oncology 20040101

• Delivering prostate cancer prevention messages to the public: how the National Cancer Institute (NCI) effectively spread the word about the Prostate Cancer Prevention Trial (PCPT) results.

  Urologic oncology 20040101

• 5 alpha-reductase and finasteride in pattern alopecia and acne.

  Journal of drugs in dermatology : JDD 20040101

• An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.

  Dermatology (Basel, Switzerland) 20040101

• [Finasteride (Propecia) and gynecomastia: 4 new cases].

  Annales de dermatologie et de venereologie 20040101

• Finasteride in the treatment of Japanese men with male pattern hair loss.

  European journal of dermatology : EJD 20040101

• Anogenital distance in human male and female newborns: a descriptive, cross-sectional study.

  Environmental health : a global access science source 20040101

• Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.

  Journal of managed care pharmacy : JMCP 20040101

• Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.

  Dermatology (Basel, Switzerland) 20040101

• Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.

  Neuroscience 20040101

• When prostate cancer markers become unreliable: the PCPT dilemma.

  Urologic oncology 20040101

• [The role of finasteride in prostate cancer].

  Lijecnicki vjesnik 20040101

• Morphology of the testis and the epididymis in rats with dihydrotestosterone (DHT) deficiency.

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20040101

• Biological profile of cortexolone 17alpha-propionate (CB-03-01), a new topical and peripherally selective androgen antagonist.

  Arzneimittel-Forschung 20040101

• Pilot attempt of advanced prostate cancer treatment T3NxMx-1 by intermittent more complete androgen blockade.

  International urology and nephrology 20040101

• [Diagnostic and prognostic value of serum prostate specific antigen in prostate carcinoma].

  Hellenic journal of nuclear medicine 20040101

• Female androgenetic alopecia treated by finasteride: a case forward.

  Acta dermato-venereologica 20040101

• Finasteride and prostate cancer.

  Reviews in urology 20040101

• 5alpha-reductase: history and clinical importance.

  Reviews in urology 20040101

• Comparison of clinical trials with finasteride and dutasteride.

  Reviews in urology 20040101

• Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.

  Urology 20031229

• The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

  The New England journal of medicine 20031218

• Medical management of benign prostatic hyperplasia--are two drugs better than one?

  The New England journal of medicine 20031218

• Prevention of prostate cancer with finasteride: US/European perspective.

  European urology 20031201

• Finasteride in polycythaemia.

  BJU international 20031201

• [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].

  MMW Fortschritte der Medizin 20031120

• Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

  British journal of cancer 20031117

• [Treatment of benign prostatic hypertrophy].

  Orvosi hetilap 20031109

• 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.

  The Journal of urology 20031101

• Does finasteride prevent prostate cancer?

  The Journal of family practice 20031101

• Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.

  Cancer research 20031101

• The clinical implications of the prostate cancer prevention trial.

  BJU international 20031101

• Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy.

  Urology 20031101

• Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.

  Urology 20031101

• Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.

  Urology 20031101

• Androgenetic alopecia: combining medical and surgical treatments.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20031101

• Response to article 'Depression circumstantially related to the administration of finasteride for androgenetic alopecia' (J Dermatol, 29, 665-669, 2002).

  The Journal of dermatology 20031101

• Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells.

  British journal of cancer 20031020

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Prevention of prostate cancer with finasteride.

  The New England journal of medicine 20031016

• Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.

  The Prostate 20031001

• Preventing prostate cancer with finasteride: a mixed blessing.

  Harvard men's health watch 20031001

• Mixed reviews for drug studied to prevent prostate cancer.

  Mayo Clinic health letter (English ed.) 20031001

• Low-dose (2.5 mg/day) finasteride treatment in hirsutism.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20031001

• Problems associated with the recognition and confirmation of low-dose endocrine toxicities.

  Nonlinearity in biology, toxicology, medicine 20031001

• [Benign prostatic syndrome. 3-step plan for the treatment].

  MMW Fortschritte der Medizin 20030925

• [Pharmacologic treatment of benign prostatic hyperplasia].

  Orvosi hetilap 20030914

• [Hair loss].

  Praxis 20030903

• Chemoprevention for prostate cancer: the Prostate Cancer Prevention Trial.

  BJU international 20030901

• Effects of androgen deprivation on chronic bacterial prostatitis in a rat model.

  International journal of urology : official journal of the Japanese Urological Association 20030901

• Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.

  Urology 20030901

• Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications.

  Urology 20030901

• Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment.

  Urology 20030901

• Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.

  Archives of dermatology 20030901

• Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.

  Archives of dermatology 20030901

• Neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats.

  Brain research 20030808

• Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat.

  Toxicological sciences : an official journal of the Society of Toxicology 20030801

• The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

  Current urology reports 20030801

• Pharmaceutical review.

  BJU international 20030801

• The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia.

  Journal of the American Academy of Dermatology 20030801

• Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life.

  International journal of impotence research 20030801

• [Androgenetic alopecia. Current aspects of a common phenotype].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030801

• [New and established methods in therapy of hair diseases].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030801

• Finasteride may prevent prostate cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030801

• Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.

  Molecular and cellular biochemistry 20030801

• Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.

  Health news (Waltham, Mass.) 20030801

• The prevention of prostate cancer--the dilemma continues.

  The New England journal of medicine 20030717

• The influence of finasteride on the development of prostate cancer.

  The New England journal of medicine 20030717

• A big study yields big questions.

  The New England journal of medicine 20030717

• Prostate cancer prevention trial yields positive results, but with a few cautions.

  Journal of the National Cancer Institute 20030716

• Stat bite: Estimated effect of finasteride on prostate cancer development.

  Journal of the National Cancer Institute 20030716

• Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030715

• Study of prostate cancer prevention drug shows potential and problems.

  Report on medical guidelines & outcomes research 20030711

• [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].

  MMW Fortschritte der Medizin 20030710

• [The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].

  MMW Fortschritte der Medizin 20030710

• Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.

  The Journal of urology 20030701

• Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.

  Endocrinology 20030701

• Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia.

  European urology 20030701

• Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.

  European urology 20030701

• Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

  Urology 20030701

• Common hair loss disorders.

  American family physician 20030701

• Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy.

  Pharmacology, biochemistry, and behavior 20030701

• Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.

  The Journal of urology 20030701

• Telling the bald truth.

  Newsweek 20030616

• Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

  The Journal of urology 20030601

• Effect of finasteride on the ovulatory function of normal women.

  Fertility and sterility 20030601

• Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).

  The journal of investigative dermatology. Symposium proceedings 20030601

• TrichoScan: a novel tool for the analysis of hair growth in vivo.

  The journal of investigative dermatology. Symposium proceedings 20030601

• [Determination of finasteride in human plasma by HPLC-MS].

  Yao xue xue bao = Acta pharmaceutica Sinica 20030601

• Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction.

  British journal of cancer 20030519

• Steroid 5alpha-reductase inhibitors.

  Mini reviews in medicinal chemistry 20030501

• Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

  The Journal of urology 20030501

• Chemoprevention for prostate cancer - the way forward?

  BJU international 20030501

• Doxazosin and finasteride alone or in combination: the PREDICT study.

  BJU international 20030501

• The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy.

  European urology 20030501

• Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery.

  European urology 20030501

• Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20030501

• The evaluation and management of hirsutism.

  Obstetrics and gynecology 20030501

• The Prostate Cancer Prevention Trial: design, status, and promise.

  World journal of urology 20030501

• Torilin from Torilis japonica, as a new inhibitor of testosterone 5 alpha-reductase.

  Planta medica 20030501

• [Relation between hypertension and clinical cases of benign prostatic hyperplasia].

  Archivos espanoles de urologia 20030501

• Current treatment options for benign prostatic hyperplasia and their impact on sexual function.

  Urology 20030401

• Familial aggregation of bothersome benign prostatic hyperplasia symptoms.

  Urology 20030401

• Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.

  Urology 20030401

• The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.

  Journal of dermatological science 20030401

• Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia.

  Journal of dermatological science 20030401

• Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

  Controlled clinical trials 20030401

• Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.

  Fertility and sterility 20030401

• Benign prostatic hyperplasia: from A - Z.

  The Canadian journal of urology 20030401

• By the way, doctor. I'm 77 and have an enlarged prostate. I take Proscar once a day and saw palmetto three times a day. Yet I still have to get up two to seven times a night to urinate. What can I do to reduce the frequency of urination?

  Harvard health letter 20030401

• Effect of acute ethanol administration and acute allopregnanolone administration on spontaneous hippocampal pyramidal cell neural activity.

  Brain research 20030328

• Saw palmetto for prostate disorders.

  American family physician 20030315

• Prostate cancer epidemiology.

  Lancet (London, England) 20030308

• Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.

  Cancer 20030301

• Seizure exacerbation associated with inhibition of progesterone metabolism.

  Annals of neurology 20030301

• Effect of a novel steroid (PM-9) on the inhibition of 5alpha-reductase present in Penicillium crustosum broths.

  Steroids 20030301

• Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.

  Urology 20030301

• Effect of androgen deprivation on penile ultrastructure.

  Asian journal of andrology 20030301

• Supplements and the prostate: widespread use, little evidence.

  Cleveland Clinic journal of medicine 20030301

• [Finasteride: 10 years of clinical use. Systematic review of the literature].

  Actas urologicas espanolas 20030301

• Third annual meeting of the Society of Urologic Oncology: Bethesda, Maryland, December 13-14, 2002.

  Clinical prostate cancer 20030301

• Prostate cancer prevention: what do we know now and when will we know more?

  Clinical prostate cancer 20030301

• [Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].

  MMW Fortschritte der Medizin 20030227

• The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction.

  The Journal of urology 20030201

• Polarographic behavior and determination of finasteride.

  Farmaco (Societa chimica italiana : 1989) 20030201

• Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up.

  Urology 20030201

• Benign prostatic hyperplasia.

  Hospital medicine (London, England : 1998) 20030201

• The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20030201

• Sexual function in patients treated for benign prostatic hyperplasia.

  Lancet (London, England) 20030104

• The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients.

  The Journal of urology 20030101

• Chronic prostatitis.

  Current opinion in urology 20030101

• 5 alpha-reductase inhibitors: what's new?

  Current opinion in urology 20030101

• Heat versus drugs in the treatment of benign prostatic hyperplasia.

  BJU international 20030101

• Treatment of hyperandrogenic alopecia in women.

  Fertility and sterility 20030101

• Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial.

  Urology 20030101

• Early diagnosis of prostate cancer in finasteride treated BPH patients.

  Anticancer research 20030101

• SELECT: the selenium and vitamin E cancer prevention trial.

  Urologic oncology 20030101

• Hormonal prevention of prostate cancer.

  Urologic oncology 20030101

• Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.

  European journal of dermatology : EJD 20030101

• Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction.

  International journal of clinical practice 20030101

• Measuring finasteride efficacy.

  Dermatology (Basel, Switzerland) 20030101

• Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.

  Journal of andrology 20030101

• A perfect correlate does not a surrogate make.

  BMC medical research methodology 20030101

• Biochemical recurrence of prostate cancer.

  Current problems in cancer 20030101

• Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.

  The Cochrane database of systematic reviews 20030101

• Cyproterone acetate for hirsutism.

  The Cochrane database of systematic reviews 20030101

• Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

  BMC cancer 20030101

• A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

  Prostate cancer and prostatic diseases 20030101

• Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.

  Proceedings of the Western Pharmacology Society 20030101

• Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate.

  Proceedings of the Western Pharmacology Society 20030101

• Therapeutic androgen receptor ligands.

  Nuclear receptor signaling 20030101

• Benign prostatic hyperplasia: does prostate size matter?

  Reviews in urology 20030101

• 5-alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia.

  Reviews in urology 20030101

• Long-Term Experience with 5-alpha-Reductase Inhibitors.

  Reviews in urology 20030101

• Landmark studies impacting the medical management of benign prostatic hyperplasia.

  Reviews in urology 20030101

• 5-alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia.

  Reviews in urology 20030101

• Long-Term Experience With 5-alpha-Reductase Inhibitors.

  Reviews in urology 20030101

• Landmark studies impacting the medical management of benign prostatic hyperplasia.

  Reviews in urology 20030101

• Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue.

  Molecular and cellular endocrinology 20021230

• Androgens and alopecia.

  Molecular and cellular endocrinology 20021230

• Dutasteride (Avodart) for benign prostatic hyperplasia.

  The Medical letter on drugs and therapeutics 20021223

• Increase in testosterone metabolism in the rat central nervous system by formalin-induced tonic pain.

  Pharmacology, biochemistry, and behavior 20021201

• Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride.

  Journal of neurochemistry 20021201

• [TrichoScan. A new instrument for digital hair analysis].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20021201

• Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.

  The Journal of clinical endocrinology and metabolism 20021201

• Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.

  Urology 20021201

• Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.

  Fertility and sterility 20021201

• Biomarker-based methods for determining noncompliance in a prevention trial.

  Controlled clinical trials 20021201

• Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful?

  Mayo Clinic health letter (English ed.) 20021201

• Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.

  Neuropharmacology 20021201

• Vapor resection: a good alternative to standard loop resection in the management of prostates >40 cc.

  Journal of endourology 20021201

• [Hormonal therapy for benign prostatic hyperplasia].

  Nihon rinsho. Japanese journal of clinical medicine 20021201

• [New agents developed for the treatment of benign prostatic hyperplasia].

  Nihon rinsho. Japanese journal of clinical medicine 20021201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021201

• Androgenetic alopecia: pathogenesis and potential for therapy.

  Expert reviews in molecular medicine 20021119

• Effects of prenatal treatment with antiandrogens on luteinizing hormone secretion and sex steroid concentrations in adult spotted hyenas, Crocuta crocuta.

  Biology of reproduction 20021101

• Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

  The Journal of urology 20021101

• Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss.

  The Journal of urology 20021101

• Hair loss in women with hyperandrogenism: four cases responding to finasteride.

  Journal of the American Academy of Dermatology 20021101

• Female pattern hair loss.

  Journal of the American Academy of Dermatology 20021101

• Changes in molecular forms of prostate-specific antigen during treatment with finasteride.

  BJU international 20021101

• Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?

  BJU international 20021101

• The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasia.

  Pharmacotherapy 20021101

• [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].

  MMW Fortschritte der Medizin 20021031

• [Drugs against symptomatic, benign prostatic hyperplasia].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20021030

• Exposure to naturally circulating androgens during foetal life incurs direct reproductive costs in female spotted hyenas, but is prerequisite for male mating.

  Proceedings. Biological sciences 20021007

• Unusual anti-angiogenic effect of combined hormonal blockade.

  The Journal of urology 20021001

• Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.

  The Journal of urology 20021001

• Finasteride for female androgenetic alopecia.

  The British journal of dermatology 20021001

• Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism.

  European journal of endocrinology 20021001

• Testosterone, cytochrome P450, and cardiac hypertrophy.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20021001

• The potential role of minoxidil in the hair transplantation setting.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20021001

• Depression circumstantially related to the administration of finasteride for androgenetic alopecia.

  The Journal of dermatology 20021001

• Phenytoin-mediated androgen metabolism in gingival fibroblasts. Effects of the antiandrogen finasteride and the alkaline phosphatase inhibitor levamisole.

  Journal of clinical periodontology 20021001

• [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].

  Archivos espanoles de urologia 20021001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021001

• Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia.

  European urology 20020901

• PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

  Urology 20020901

• Changes in expression of the neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery.

  Journal of neurochemistry 20020901

• [Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia].

  Der Urologe. Ausg. A 20020901

• [Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results].

  Der Urologe. Ausg. A 20020901

• [Drug therapy of benign prostatic hyperplasia. Is combination therapy with 5 alpha-reductase inhibitors and alpha-receptor blockers effective?].

  Der Urologe. Ausg. A 20020901

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020901

• Finasteride-induced thrombocytopenia.

  BJU international 20020801

• Nonsurgical management of benign prostatic hyperplasia in men with bladder calculi.

  Urology 20020801

• Synthesis and evaluation of 2'-substituted 4-(4'-carboxy- or 4'-carboxymethylbenzylidene)-N-acylpiperidines: highly potent and in vivo active steroid 5alpha-reductase type 2 inhibitors.

  Journal of medicinal chemistry 20020801

• Medical therapy for benign prostatic hyperplasia progression.

  Current urology reports 20020801

• A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.

  Clinical endocrinology 20020801

• Two-drug therapy is best for symptomatic prostate enlargement: combination should change clinical practice.

  Journal of the American College of Surgeons 20020801

• Comparative efficacy of various treatment regimens for androgenetic alopecia in men.

  The Journal of dermatology 20020801

• Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.

  The Kaohsiung journal of medical sciences 20020801

• Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.

  European urology 20020701

• Managing benign prostatic hyperplasia.

  American family physician 20020701

• Oral contraceptives as anti-androgenic treatment of acne.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20020701

• Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.

  The Journal of urology 20020601

• 13C-NMR study of 4-azasteroids in solution and solid state.

  Steroids 20020601

• Effects of the chronic use of finasteride on testicular weight and spermatogenesis in Wistar rats.

  BJU international 20020601

• Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.

  International journal of oncology 20020601

• Testosterone stimulates proliferation and inhibits interleukin-6 production of normal and hereditary gingival fibromatosis fibroblasts.

  Oral microbiology and immunology 20020601

• Reporting of acute urinary retention in BPH treatment trials: importance of patient follow-up after discontinuation and case definitions.

  Urology 20020601

• 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.

  Pharmacogenetics 20020601

• On call. I am a 64-year-old man, and I've always been proud of my perfect health record. I've also been proud of my full head of hair, even after the gray started creeping in. Four months ago I caught pneumonia and spent eight days in the hospital (three in intensive care). It took a while, but I'm finally back to normal - except that my hair is falling out. It comes out in clumps when I shampoo or even comb it, and it's gotten noticeably thin all over. I remember reading about Propecia in your newsletter b

  Harvard men's health watch 20020601

• [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20020601

• Concept evaluation: an assay for receptor-mediated and biochemical antiestrogens using pubertal rats.

  Regulatory toxicology and pharmacology : RTP 20020601

• Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.

  Life sciences 20020531

• The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.

  The Journal of urology 20020501

• Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats.

  Hormones and behavior 20020501

• Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20020501

• Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

  European urology 20020501

• [Androgenetic alopecia in the man].

  Therapeutische Umschau. Revue therapeutique 20020501

• Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20020501

• [Hirsutism and hypertrichosis in adults: investigations and treatment].

  Annales de dermatologie et de venereologie 20020501

• [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].

  MMW Fortschritte der Medizin 20020418

• Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output.

  Brain research 20020405

• Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.

  Journal of the American Academy of Dermatology 20020401

• Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.

  The Journal of urology 20020401

• Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.

  American journal of veterinary research 20020401

• Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride.

  Archives of dermatology 20020401

• Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.

  BJU international 20020401

• Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

  World journal of urology 20020401

• The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.

  World journal of urology 20020401

• A rapid method for obtaining finasteride, a 5alpha-reductase inhibitor, from commercial tablets.

  Brain research. Brain research protocols 20020401

• GABAergic neurosteroid modulation of ethanol actions.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20020401

• Anti-androgens for the treatment of hirsutism.

  Expert opinion on investigational drugs 20020301

• Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.

  Urology 20020301

• My hair is thinning on the top of my head. What treatments are available for hair loss in women?

  Health news (Waltham, Mass.) 20020301

• Synthesis and biological evaluation of 4-(4-(alkyl- and phenylaminocarbonyl)benzoyl)benzoic acid derivatives as non-steroidal inhibitors of steroid 5 alpha-reductase isozymes 1 and 2.

  Archiv der Pharmazie 20020301

• [Experimental study on effect of xiaolong tongbi on nitric oxide synthase and epithelial cell apoptosis in prostate of rats].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20020301

• Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia.

  BJU international 20020201

• Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects.

  BJU international 20020201

• Inhibitors of 5alpha -reductase type I in LNCaP cells from the roots of Angelica koreana.

  Planta medica 20020201

• The effect of finasteride in men with benign prostatic hyperplasia. 1992.

  The Journal of urology 20020201

• [Propecia: testimony from monozygotic twins].

  Revue de l'infirmiere 20020201

• Causes of hair loss and the developments in hair rejuvenation.

  International journal of cosmetic science 20020201

• Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women.

  Maturitas 20020130

• Transurethral resection of the prostate: the new old standard.

  Current opinion in urology 20020101

• Finasteride improves male pattern hair loss in a randomized study in identical twins.

  European journal of dermatology : EJD 20020101

• Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.

  European journal of dermatology : EJD 20020101

• The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia.

  BMC urology 20020101

• Synthesis and pharmacological evaluation of new 16-methyl pregnane derivatives.

  Chemical & pharmaceutical bulletin 20020101

• Hypothalamic 5 alpha-reductase and 3 alpha-oxidoreductase activity in the male rat.

  The Journal of steroid biochemistry and molecular biology 20020101

• [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].

  Urologiia (Moscow, Russia : 1999) 20020101

• Effects of finasteride on apoptosis and regulation of the human hair cycle.

  Journal of cutaneous medicine and surgery 20020101

• Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case-control study.

  Pharmacoepidemiology and drug safety 20020101

• [Results of the effectiveness of long-term treatment of patients with benign prostatic hyperplasia].

  Urologiia (Moscow, Russia : 1999) 20020101

• Update on the medical management of benign prostatic hyperplasia.

  International urology and nephrology 20020101

• Serenoa repens for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20020101

• Comparison of deferral rates using a computerized versus written blood donor questionnaire: a randomized, cross-over study [ISRCTN84429599].

  BMC public health 20020101

• Effects of finasteride on vascular endothelial growth factor.

  Scandinavian journal of urology and nephrology 20020101

• Molecular mechanisms of androgenetic alopecia.

  Experimental gerontology 20020101

• [Treatment of benign prostatic hypertrophy: present situation and future prospects].

  Actas urologicas espanolas 20020101

• [Use of proscar in preoperative preparation of patients with benign prostatic hyperplasia before transureteral resection].

  Urologiia (Moscow, Russia : 1999) 20020101

• 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.

  Proceedings of the Western Pharmacology Society 20020101

• Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.

  Urologia internationalis 20020101

• Influence of new evidence on prescription patterns.

  The Journal of the American Board of Family Practice 20020101

• Chemoprevention of prostate cancer.

  Cancer metastasis reviews 20020101

• Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.

  BMC urology 20020101

• Terazosin for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20020101

• Comparison of tamsulosin and finasteride for lower urinary tract symptoms associated with benign prostatic hyperplasia in Korean patients.

  The Journal of international medical research 20020101

• Chemoprevention of prostate carcinogenesis by DFMO and/or finasteride treatment in male Wistar rats.

  Tumori 20020101

• [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].

  Therapie 20020101

• The potential for prostate cancer chemoprevention.

  Reviews in urology 20020101

• Reducing the risk of benign prostatic hyperplasia progression.

  Reviews in urology 20020101

• Ventral tegmental area infusions of inhibitors of the biosynthesis and metabolism of 3alpha,5alpha-THP attenuate lordosis of hormone-primed and behavioural oestrous rats and hamsters.

  Journal of neuroendocrinology 20011201

• Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride.

  Urology 20011201

• 5alpha-reductase activity in the prostate.

  Urology 20011201

• Minimally invasive therapies for benign prostatic hyperplasia.

  Urology 20011201

• 5alpha-reductase inhibitors: what role should they play?

  Urology 20011201

• Finasteride. Does it affect spermatogenesis and pregnancy?

  Canadian family physician Medecin de famille canadien 20011201

• The future of prostate cancer prevention.

  Annals of the New York Academy of Sciences 20011201

• Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective.

  BJU international 20011201

• [Photographic documentation of the effectiveness of 1 mg. oral finasteride in treatment of androgenic alopecia in the man in routine general practice in Switzerland].

  Praxis 20011129

• Separation of finasteride and analogues.

  Journal of chromatography. B, Biomedical sciences and applications 20011125

• Baldness. Medical solutions for men and women.

  Mayo Clinic health letter (English ed.) 20011101

• Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone.

  Kidney international 20011101

• Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.

  Biochemical pharmacology 20011001

• Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate.

  The Journal of endocrinology 20011001

• Progesterone and 3alpha,5alpha-THP enhance sexual receptivity in mice.

  Behavioral neuroscience 20011001

• Replacement of surgical castration by GnRH-inhibition or Leydig cell ablation in the male rat Hershberger antiandrogen assay.

  Regulatory toxicology and pharmacology : RTP 20011001

• Increased expression of the neuropeptide Y receptor Y(1) gene in the medial amygdala of transgenic mice induced by long-term treatment with progesterone or allopregnanolone.

  Journal of neurochemistry 20011001

• Managing benign prostatic hyperplasia.

  The Practitioner 20011001

• Anxiolytic effect of Kami-Shoyo-San (TJ-24) in mice: possible mediation of neurosteroid synthesis.

  Life sciences 20010921

• A novel class of inhibitors for steroid 5alpha-reductase: synthesis and evaluation of umbelliferone derivatives.

  Bioorganic & medicinal chemistry letters 20010903

• Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss.

  Journal of the American Academy of Dermatology 20010901

• Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

  Cancer causes & control : CCC 20010901

• New progesterone esters as 5alpha-reductase inhibitors.

  Chemical & pharmaceutical bulletin 20010901

• Direct-to-consumer advertising. Finasteride for male pattern hair loss.

  Canadian family physician Medecin de famille canadien 20010901

• Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20010901

• Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP.

  Cellular and molecular biology (Noisy-le-Grand, France) 20010901

• Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors.

  Cognitive, affective & behavioral neuroscience 20010901

• Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia.

  Urology 20010801

• Neurosteroids mediate habituation and tonic inhibition in the auditory midbrain.

  Journal of neurophysiology 20010801

• Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.

  Urology 20010801

• Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.

  Urology 20010801

• Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia.

  Urology 20010801

• The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery.

  World journal of urology 20010801

• Effects of different steroid-biosynthesis inhibitors on the testicular steroidogenesis of the toad Bufo arenarum.

  Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20010801

• Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.

  Seminars in oncology 20010801

• Hormonal treatment of patients with benign prostatic hyperplasia: pros and cons.

  Current urology reports 20010801

• [Prostate problems. More clarity regarding prognosis].

  MMW Fortschritte der Medizin 20010726

• The appropriateness of treatment of benign prostatic hyperplasia: a comparison of Dutch and multinational criteria.

  Health policy (Amsterdam, Netherlands) 20010701

• LC determination of finasteride and its application to storage stability studies.

  Journal of pharmaceutical and biomedical analysis 20010701

• A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly L-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from benign prostatic hyperplasia.

  BJU international 20010701

• The 'Dorian Gray Syndrome': psychodynamic need for hair growth restorers and other 'fountains of youth.'.

  International journal of clinical pharmacology and therapeutics 20010701

• Body dysmorphic disorder and life-style drugs. Overview and case report with finasteride.

  International journal of clinical pharmacology and therapeutics 20010701

• Management of male pattern hair loss.

  Cutis 20010701

• [Wellbeing or happiness medications?].

  Atencion primaria 20010630

• Effect of finasteride on behavioural arousal and somatosensory evoked potentials in fetal sheep.

  Neuroscience letters 20010622

• Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.

  The Journal of biological chemistry 20010615

• Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo.

  Journal of molecular endocrinology 20010601

• Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.

  Urology 20010601

• Questions whether clients were properly informed about treatment protocol.

  Journal of the American Veterinary Medical Association 20010601

• Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data.

  BJU international 20010601

• Inhibition of 5alpha-reductase enzyme or GABA(A) receptors in the VMH and the VTA attenuates progesterone-induced sexual behavior in rats and hamsters.

  Journal of endocrinological investigation 20010601

• Prevention of prostate cancer.

  Hematology/oncology clinics of North America 20010601

• Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

  Journal of clinical epidemiology 20010501

• Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.

  Urology 20010501

• Structure-function studies of human 5-alpha reductase type 2 using site directed mutagenesis.

  The Journal of steroid biochemistry and molecular biology 20010501

• Evaluation of new pregnane derivatives as 5alpha-reductase inhibitor.

  Chemical & pharmaceutical bulletin 20010501

• [Gynecomastia and finasteride].

  Annales de dermatologie et de venereologie 20010501

• Narcissus drowned.

  Lancet (London, England) 20010428

• Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.

  Journal of the American Veterinary Medical Association 20010415

• As genes differ, so should interventions for cancer.

  JAMA 20010411

• Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats.

  Toxicological sciences : an official journal of the Society of Toxicology 20010401

• Enlarged prostate gland. Many treatment options.

  Mayo Clinic health letter (English ed.) 20010401

• Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

  Urology 20010401

• Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents.

  Urology 20010401

• Androgen antagonists: Potential role in prostate cancer prevention.

  Urology 20010401

• The Prostate Cancer Prevention Trial: Current status and lessons learned.

  Urology 20010401

• Cost-sharing for prescriptions of sildenafil and finasteride: a case study in veteran patients.

  The American journal of managed care 20010401

• Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain.

  The Journal of clinical endocrinology and metabolism 20010301

• Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.

  Fertility and sterility 20010301

• Acute pancreatitis possibly related to finasteride.

  Journal of clinical gastroenterology 20010301

• Benign prostatic hyperplasia. Patient evaluation and relief of obstructive symptoms.

  Geriatrics 20010301

• Clinical application of 5alpha-reductase inhibitors.

  Journal of endocrinological investigation 20010301

• [Long-term therapy of benign prostatic hyperplasia. Our experience].

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20010301

• Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.

  Epilepsia 20010301

• Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.

  Epilepsia 20010301

• [Hair loss].

  Ugeskrift for laeger 20010226

• [Status of scalp hair and therapy of alopecia in men in Switzerland].

  Praxis 20010215

• Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.

  Archives of oral biology 20010201

• Management of lower urinary tract symptoms of elderly men in Austria.

  European urology 20010201

• Bioequivalence study of finasteride. Determination in human plasma by high-pressure liquid chromatography coupled to tandem mass spectrometry.

  Arzneimittel-Forschung 20010201

• Pharmacogenetics of human androgens and prostatic diseases.

  Pharmacogenomics 20010201

• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.

  The Journal of urology 20010101

• Minimally invasive procedures as an alternative to medical management for lower urinary tract symptoms of benign prostatic hyperplasia.

  Current opinion in urology 20010101

• Is there a place for combination medical therapy?

  Current opinion in urology 20010101

• Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.

  The Prostate 20010101

• Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.

  Journal of andrology 20010101

• Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.

  Drugs 20010101

• Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin for bladder outlet obstruction.

  Urologia internationalis 20010101

• Finasteride cream in hirsutism.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• Topical finasteride therapy in hirsutism.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• Lower urinary tract symptoms suggestive of benign prostatic obstruction: what is the available evidence for rational management?

  European urology 20010101

• Lower urinary tract symptoms suggestive of benign prostatic obstruction: how can clinical expertise contribute to rational management?

  European urology 20010101

• Lower urinary tract symptoms suggestive of benign prostatic obstruction--what's the long-term effectiveness of medical therapies?

  European urology 20010101

• Lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the current practice patterns?

  European urology 20010101

• Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: the role of general practice databases.

  European urology 20010101

• Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

  PharmacoEconomics 20010101

• Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.

  The oncologist 20010101

• A risk-benefit assessment of pharmacological therapies for hirsutism.

  Drug safety 20010101

• Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.

  European journal of dermatology : EJD 20010101

• Steroidogenic enzymes in skin.

  European journal of dermatology : EJD 20010101

• Androgen responsive genes as they affect hair growth.

  European journal of dermatology : EJD 20010101

• Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.

  European journal of dermatology : EJD 20010101

• TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.

  European journal of dermatology : EJD 20010101

• Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.

  Gene expression 20010101

• The value of hair cosmetics and pharmaceuticals.

  Dermatology (Basel, Switzerland) 20010101

• Finasteride: a long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia.

  Urologia internationalis 20010101

• Hirsutism: diagnosis and management.

  The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 20010101

• Stable expression of the human 5alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors.

  Journal of enzyme inhibition 20010101

• [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].

  Urologiia (Moscow, Russia : 1999) 20010101

• Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

  International urology and nephrology 20010101

• Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.

  Nutrition and cancer 20010101

• Management of patients with LUTS suggestive of BPH.

  European urology 20010101

• Online prescriptions of pharmaceuticals: where is the evidence for harm or for benefit? A call for papers--and for reflection.

  Journal of medical Internet research 20010101

• Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.

  PharmacoEconomics 20010101

• Long-term aspects of medical treatment of BPH.

  European urology 20010101

• Quality of life and sexuality: methodological aspects.

  European urology 20010101

• Lower urinary tract symptoms: what are the implications for the patients?

  European urology 20010101

• Initial choices and final outcomes in lower urinary tract symptoms.

  European urology 20010101

• Determination of concentrations of sex steroids in blood plasma and semen of male dogs treated with delmadinone acetate or finasteride.

  Journal of reproduction and fertility. Supplement 20010101

• Inhibition of sodium acetate incorporation into lipids by novel steroids in hamster flank organs.

  Proceedings of the Western Pharmacology Society 20010101

• Management of hirsutism in women of Mediterranean origin.

  Le Journal medical libanais. The Lebanese medical journal 20010101

• Saw Palmetto Berry as a Treatment for BPH.

  Reviews in urology 20010101

• Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.

  Cancer research 20001201

• Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer.

  BJU international 19990101

• Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.

  Urology 19980501

• The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

  The New England journal of medicine 19980226

• A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.

  Cancer 19980201

• [Combined use of 5 alpha-reductase inhibitors and alpha-l adrenergic receptor blockers in patients with benign prostatic hyperplasia].

  Urologiia i nefrologiia 19980101

• Reversible severe myopathy during treatment with finasteride.

  Muscle & nerve 19970401

• Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19961101

• The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.

  British journal of urology 19960901

• Vinyl fluoride as a mimic of the 'intermediate' enol form in the 5 alpha-reductase transformation: synthesis and in vitro activity of (N-1',1'-dimethylethyl)-3-haloandrost-3,5-diene-17 beta-carboxamides.

  Bioorganic & medicinal chemistry 19960101

• The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.

  The Journal of urology 19951101

• [Effects of androgen regulation system on bladder carcinogenesis in male mice].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19951101

• Five-year follow-up of patients with benign prostatic hyperplasia treated with finasteride.

  European urology 19950101

• Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.

  The Journal of steroid biochemistry and molecular biology 19940301

• Treatment of advanced prostate cancer with the combination of finasteride plus flutamide: early results.

  European urology 19930101

• Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.

  Journal of medicinal chemistry 19861101

• Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17.

  Molecular endocrinology (Baltimore, Md.)